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The employer is required to post a copy of this report for 30 days at or near the 
workplace(s) of affected employees. The employer must take steps to ensure 
that the posted report is not altered, defaced, or covered by other material.
The cover photo is a close-up image of sorbent tubes, which are used by the HHE
Program to measure airborne exposures. This photo is an artistic representation that may
not be related to this Health Hazard Evaluation.
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We evaluated respiratory 
health and airborne exposures 
to alpha-diketones (diacetyl, 
2,3-pentanedione, and 
2,3-hexanedione), other volatile 
organic compounds, carbon 
monoxide, and carbon dioxide 
during coffee roasting, grinding, 
and packaging. Diacetyl and 
2,3-pentanedione were detected 
in all full-shift personal breathing 
zone air samples, with a maximum 
diacetyl concentration of 25.6 parts 
per billion and 2,3-pentanedione 
concentration of 15.8 parts per 
billion. Seventy-eight percent of 
the full-shift personal samples 
exceeded the NIOSH recommended 
exposure limit for diacetyl of 5 
parts per billion. In addition, air 
sampling during short-term tasks 
identified several tasks (e.g., re-work 
of packaged coffee, moving roasted 
beans or ground coffee, grinding 
coffee) with higher exposures to 
alpha-diketones, including diacetyl, 
than other tasks. Nose, eye, sinus, 
and lower respiratory symptoms 
were among the most commonly 
reported symptoms. Wheezing 
and breathing trouble were the 
most common lower respiratory 
symptoms reported. Having current 
asthma was over 2.5 times higher 
than that expected compared with 
the U.S. population with the same 
distribution. No participants had 
abnormal spirometry results. We 
recommend limiting employee 
exposures to alpha-diketones using 
engineering and administrative 
controls. We also recommend 
training employees about 
workplace hazards and instituting a 
medical monitoring program.
Highlights of this Evaluation
The Health Hazard Evaluation Program of the National Institute for Occupational Safety 
and Health (NIOSH) received a request from the management of a coffee roasting and 
packaging facility regarding concerns about exposures to and health effects from diacetyl and 
2,3-pentanedione during coffee roasting, grinding, and packaging.
What We Did
 ● We visited the coffee processing facility 
on April 18–22, 2016 and April 25–29, 
2016.
 ● We collected full-shift (hours), task 
(minutes), and instantaneous (seconds) 
air samples to measure concentrations 
of the alpha-diketones diacetyl, 
2,3-pentanedione and 2,3-hexandione 
over multiple days.
 ● We collected roasted coffee beans 
(whole bean and ground) to measure 
their emission potential for diacetyl, 
2,3-pentanedione, and 2,3-hexanedione. 
 ● We measured real-time air levels of 
carbon monoxide and carbon dioxide. 
 ● We assessed the facility’s ventilation 
system.
 ● We administered a health questionnaire 
to employees and performed breathing 
tests.
What We Found
 ● Diacetyl concentrations were above the 
NIOSH recommended exposure limit of 
5 parts per billion in 78% of the full-shift 
personal samples. 
 ● 2,3-Pentanedione concentrations were 
above the NIOSH recommended 
exposure limit of 9.3 parts per billion in 
8% of the full shift personal samples.
 ● Employees in packaging had the highest 
average personal exposure to diacetyl of 
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13.2 parts per billion, with a maximum concentration of 25.6 parts per billion.
 ● The highest full-shift area samples were collected in grinding (diacetyl of 68.9 parts per 
billion and 2,3-pentanedione of 31.4 parts per billion). The roasting area had the second 
highest levels of diacetyl (37.8 parts per billion) and 2,3-pentanedione (23.0 parts per 
billion).
 ● Levels of diacetyl and 2,3-pentanedione in the air during short-term sampling were 
higher for tasks involving re-work of packaged coffee, moving roasted whole bean or 
ground coffee, and grinding coffee.
 ● There were opportunities for air from the production room to enter the office areas.
 ● Nose and eye symptoms were the most commonly reported symptoms. 
 ● Wheezing and breathing trouble were the most commonly reported lower respiratory 
symptoms; nearly two times as many employees reported wheezing as expected. 
 ● Approximately 2.5 times as many employees reported having current asthma as 
expected.
 ● None of the 75 participants tested had abnormal spirometry results.
 ● Six of 78 participants had elevated exhaled nitric oxide, a marker of allergic airways 
inflammation.
What the Employer Can Do
 ● Ensure employees understand potential hazards (e.g., diacetyl, 2,3-pentanedione, 
carbon monoxide, carbon dioxide, green and roasted coffee dust) in the workplace and 
how to protect themselves.
 ● Limit the amount of time non-production employees spend in the production area.
 ● Keep all doors between the production and non-production areas closed at all times.
 ● Work with a ventilation engineer to ensure the production area is maintained under 
negative pressure compared with non-production spaces.
 ● Isolate or relocate the main grinder.
 ● Install local exhaust ventilation at the point sources with the highest concentrations of 
alpha-diketones. 
 ● Conduct follow-up air sampling to verify the modifications have been effective in 
reducing exposures to below the recommended exposure limits. If modifications have 
not been effective, continue to work with a ventilation engineer to improve local 
exhaust and general ventilation to reduce exposures below recommended exposure 
limits. Also, until exposures are controlled, provide respiratory protection to be used 
during tasks with elevated exposures.
 ● Make N95 disposable filtering facepiece respirators available for voluntary use for 
protection against dust exposure such as when emptying burlap bags of green beans 
into the storage silos feed hopper, cleaning the exhaust system of chaff, emptying the 
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chaff containers, or cleaning the green bean storage area. 
 ● Encourage employees to report new or ongoing respiratory symptoms to their personal 
healthcare providers and to a designated individual at the workplace.
 ● Institute a medical monitoring program for employees who work in the production area 
and in quality control.
What Employees Can Do
 ● Once local exhaust ventilation is installed, use it as instructed by your employer.
 ● As much as possible, avoid placing your head directly near sources of roasted or 
ground coffee beans, such as supersacks.
 ● Some employees might wish to use N95 disposable filtering facepiece respirators for 
some tasks, such as when emptying burlap bags of green beans into the storage silos 
feed hopper, cleaning the chaff out of the roaster exhaust system, emptying the chaff 
containers, or cleaning the green bean storage area.
 ● Participate in any personal air sampling offered by your employer.
 ● Report new or ongoing respiratory symptoms to your personal healthcare provider and 
a designated individual at your workplace.
 ● Participate in your employer’s medical monitoring program as instructed by your 
employer.
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Abbreviations
µg Microgram
°F  degrees Fahrenheit
ACGIH® American Conference of Governmental Industrial Hygienists
AX Area of reactance
CFR Code of Federal Regulations
CI Confidence interval
CO Carbon monoxide
CO2 Carbon dioxide
COHb                   Carboxyhemoglobin
COPD Chronic obstructive pulmonary disease
DR5-R20 The difference between resistance at 5 and 20 Hertz
FEV1 1-second forced expiratory volume
Fres  Resonant frequency
FVC Forced vital capacity
Hz Hertz
kg/m2   Kilogram per square meter
kPa/(L/s)  Kilopascals per liter per second
IDLH Immediately dangerous to life or health
LOD Limit of detection
LOQ Limit of quantitation
mL Milliliter
mL/min Milliliter per minute
NHANES National Health and Nutrition Examination Survey
NIOSH National Institute for Occupational Safety and Health
OEL Occupational exposure limit
OSHA Occupational Safety and Health Administration
PEL Permissible exposure limit
ppb Parts per billion
ppm Parts per million
R5 Resistance at 5 Hertz
R20 Resistance at 20 Hertz
REL Recommended exposure limit
RH Relative humidity
SMR Standardized morbidity ratios 
STEL Short-term exposure limit
TLV® Threshold limit value
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TVOC Total volatile organic compound
TWA Time-weighted average
US United States
VOC Volatile organic compound
X5 Reactance at 5 Hertz
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Summary
In October 2015, the National Institute for Occupational Safety and Health’s Health Hazard 
Evaluation Program received a request from the management of a coffee roasting and 
packaging facility with 94 employees. The request stated concerns about exposures to and 
health effects from diacetyl and 2,3-pentanedione during coffee roasting, grinding, and 
packaging. In April 2016, we conducted a ventilation assessment of the production and 
office areas, industrial hygiene survey, and medical survey at the facility. The industrial 
hygiene survey consisted of collecting personal breathing zone and area air samples for 
alpha-diketones (i.e., diacetyl, 2,3-pentanedione, and 2,3-hexanedione). We used continuous 
monitoring instruments to measure total volatile organic compounds, carbon monoxide, 
carbon dioxide, temperature, and relative humidity in specific areas and during tasks. We 
also measured levels of carbon monoxide in employees’ exhaled breath. The medical survey 
consisted of a health questionnaire and breathing tests.
Sixty-nine of the 88 full-shift personal samples collected exceeded the NIOSH recommended 
exposure limit for diacetyl of 5 parts per billion, with a maximum concentration of 25.6 
parts per billion. We identified jobs where some work tasks resulted in relatively higher air 
concentrations of diacetyl than other tasks. Specifically, rework of packaged coffee, moving 
roasted beans or ground coffee, grinding coffee beans, and packaging coffee were associated 
with higher diacetyl levels. 
Overall, the most commonly reported symptoms were nose and eye symptoms. Some 
production employees reported their nose and sinus symptoms were caused or aggravated by 
green coffee dust or chaff, roasted coffee dust, or ground coffee dust. Wheezing or whistling 
in the chest was the most commonly reported lower respiratory symptom, and was nearly 
two times higher than that expected compared with the U.S. population of the same age, race/
ethnicity, sex, and cigarette smoking distribution. No participants had abnormal spirometry 
tests. We recommend installing local exhaust ventilation at the point sources with the highest 
concentrations of alpha-diketones. In addition to local exhaust ventilation, we recommend 
isolating or re-locating the main grinder. We also recommend a medical monitoring program 
to identify any employees who might be developing work-related lung disease (e.g., asthma, 
obliterative bronchiolitis) and to help management prioritize interventions to prevent 
occupational lung disease.
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Introduction
In October 2015, the National Institute for Occupational Safety and Health (NIOSH) received 
a management request for a health hazard evaluation at a coffee roasting and packaging 
facility regarding potential worker exposure to diacetyl and 2,3-pentanedione during coffee 
processing. In April 2016, we conducted an industrial hygiene survey, ventilation assessment, 
and medical survey. We collected area and personal breathing zone air samples for volatile 
organic compounds (VOCs), including diacetyl, 2,3-pentanedione, and 2,3-hexanedione. We 
also monitored carbon monoxide (CO), carbon dioxide (CO2), and total VOCs. 
Background
Diacetyl and 2,3-Pentanedione 
Diacetyl (2,3-butanedione) and 2,3-pentanedione (acetyl propionyl) are VOCs known as 
alpha-diketones that are added as ingredients in food flavorings used in some food products 
such as microwave popcorn, bakery mixes, and flavored coffee [Day et al. 2011; Kanwal et 
al. 2006; Bailey et al. 2015]. Diacetyl, 2,3-pentanedione, other VOCs, and gases such as CO 
and CO2 are naturally produced and released during the coffee roasting process [Duling et al. 
2016; Raffel and Thompson 2013; Daglia et al. 2007; Nishimura et al. 2003; Newton 2002]. 
Grinding roasted coffee beans produces a greater surface area for off-gassing (sometimes 
called degassing) of these compounds [Akiyama et al. 2003]. Often, coffee roasting facilities 
package newly roasted coffee in permeable bags or in bags fitted with one-way valves to 
allow the coffee to off-gas after it is packaged. Sometimes, newly roasted coffee is placed in 
bins or containers and allowed to off-gas before packaging. 
NIOSH has recommended exposure limits (RELs) for diacetyl and 2,3-pentanedione in 
workplace air (Table 1) [NIOSH 2016]. The NIOSH objective in establishing RELs for 
diacetyl and 2,3-pentanedione was to reduce the risk of respiratory impairment (decreased 
lung function) and the severe irreversible lung disease obliterative bronchiolitis associated 
with occupational exposure to these chemicals. The NIOSH RELs are intended to protect 
workers exposed to diacetyl or 2,3-pentanedione for a 45-year working lifetime. The REL for 
diacetyl is based on a quantitative risk assessment which necessarily contains assumptions 
and some uncertainty. Analytical limitations current at the time were taken into consideration 
in setting the REL for 2,3-pentanedione. The RELs should be used as a guideline to indicate 
when steps should be taken to reduce exposures in the workplace.
These exposure limits and the accompanying recommendations for control of exposures 
were derived from a risk assessment of flavoring-exposed workers. At an exposure equal 
to the diacetyl REL, the risk of adverse health effects is low. NIOSH estimated that less 
than 1 in 1,000 workers exposed to diacetyl levels of 5 parts per billion (ppb) as a time-
weighted average (TWA) for 8 hours a day, 40 hours a week for a 45-year working lifetime 
would develop reduced lung function (defined as forced expiratory volume in one second 
[FEV1] below the 5th percentile) as a result of that exposure. NIOSH predicted that around 
1 in 10,000 workers exposed to diacetyl at 5 ppb for a 45-year working lifetime would 
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develop more severe lung function reduction (FEV1 below 60% predicted, defined as at 
least moderately severe by the American Thoracic Society [Pellegrino et al. 2005]). Workers 
exposed for less time would be at lower risk for adverse lung effects.
2,3-Hexanedione
2,3-Hexanedione is also an alpha-diketone that is sometimes used as a substitute for diacetyl 
and is produced naturally during coffee roasting. In a study using animals, there was some 
evidence that 2,3-hexanedione might also damage the lungs, but it appeared to be less 
toxic than diacetyl and 2,3-pentanedione [Morgan et al. 2016]. There are no established 
occupational exposure limits for 2,3-hexanedione.
Carbon Monoxide and Carbon Dioxide
CO and CO2 are gases produced by combustion. They are also produced as a result of 
reactions that take place during coffee roasting. These gases are released during and after 
roasting and grinding by a process called off-gassing [Anderson et al. 2003]. High exposures 
to CO and CO2 can cause headache, dizziness, fatigue, nausea, altered mentation, rapid 
breathing, impaired consciousness, coma, and death [Newton 2002; Nishimura et al. 2003; 
Langford 2005; CDC 2013; Raffel and Thompson 2013; Rose et al. 2017]. Occupational 
exposure limits for CO and CO2 are listed in Table 1.
Exposure Limits
We use mandatory (legally enforceable) and recommended occupational exposure limits 
(OELs) when evaluating workplace hazards. OELs have been developed by federal agencies 
and safety and health organizations to prevent adverse health effects from workplace 
exposures.
Occupational Safety and Health Administration (OSHA)
The U.S. Department of Labor’s OSHA permissible exposure limits (PELs) are legal limits 
enforceable in workplaces covered under the Occupational Safety and Health Act. OSHA 
PELs represent the legal maximum for a TWA exposure to a physical or chemical agent 
over a work shift [OSHA 2017]. OSHA short term exposure limits (STELs) are the legal 
maximum average exposure for a 15-minute time period. Some chemicals also have an 
OSHA ceiling value that represent levels that must not be exceeded at any time. Currently, 
there are no PELs for diacetyl, 2,3-pentanedione or 2,3-hexanedione. For substances for 
which an OSHA PEL has not been issued, violation of the OSHA General Duty Clause 
can be considered using available occupational exposure references and recommendations 
[OSHA 1993; OSHA 2003], such as the American Conference of Governmental Industrial 
Hygienists (ACGIH) Threshold Limit Values (TLVs®) and NIOSH RELs.
American Conference of Governmental Industrial Hygienist (ACGIH®) 
ACGIH is a professional, not-for-profit scientific association that reviews existing published, 
peer-reviewed scientific literature and publishes recommendations for levels of substances 
in air based on an 8-hour workday and 40-hour workweek. These recommendations are 
called TLVs [ACGIH 2017a]. ACGIH TLVs are not standards; they are health-based 
guidelines derived from scientific and toxicological information. ACGIH provides TLV-TWA 
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guidelines that are levels that should not be exceeded during any 8-hour workday of a 40-
hour workweek. ACGIH also provides TLV-STEL guidelines which are 15-minute exposure 
levels that should not be exceeded during a workday. Exposures above the TLV-TWA but less 
than the TLV-STEL should be (1) less than 15 minutes, (2) occur no more than four times a 
day, and (3) be at least 60 minutes between exposures [ACGIH 2017a]. Additionally, ACGIH 
provides TLV-Ceiling values which are levels that should not be exceeded at any time during 
a work shift. The ACGIH TLV-TWA for diacetyl is 10 ppb. The TLV-STEL for diacetyl is 20 
ppb. Currently, there is no TLV-TWA or TLV-STEL for 2,3-pentanedione. ACGIH has placed 
2,3-pentanedione on the 2017 list of Chemical Substances and Other Issues Under Study 
[ACGIH 2017b].   
National Institute for Occupational Safety and Health (NIOSH)
NIOSH provides RELs as TWA concentrations that should not be exceeded over an 8 or 
10-hour work shift, during a 40-hour workweek [NIOSH 2010]. RELs are intended to 
be protective over a 45-year working lifetime. NIOSH also provides STELs which are 
15-minute TWA exposures that should not be exceeded at any time during a workday 
[NIOSH 2010]. Some chemicals have ceiling values which are concentrations that should 
not be exceeded at any time [NIOSH 2010]. For some chemicals, NIOSH has Immediately 
Dangerous to Life or Health (IDLH) values. An IDLH value is a concentration of an air 
contaminant that can cause death or immediate or delayed permanent adverse health effects, 
or prevent escape from such an environment. Currently, NIOSH has RELs and STELs for 
diacetyl and 2,3-pentanedione. NIOSH does not have a REL or a STEL for 2,3-hexanedione. 
NIOSH does not have ceiling limits or IDLH values for diacetyl, 2,3-pentanedione, or 
2,3-hexanedione. 
For diacetyl and 2,3-pentanedione, the NIOSH RELs are 5.0 ppb and 9.3 ppb, respectively, 
as a TWA for up to an 8-hour workday during a 40-hour workweek (Table 1). The NIOSH 
STELs are 25 ppb for diacetyl and 31 ppb for 2,3-pentanedione [NIOSH 2016]. The NIOSH 
exposure standards do not differentiate between natural and synthetic chemical origin of 
diacetyl or 2,3-pentanedione. Although the NIOSH exposure limit for 2,3-pentanedione 
is above that of diacetyl, 2,3-pentanedione has been shown to be as hazardous as diacetyl 
[Hubbs et al. 2012; Morgan et al. 2012]. The hazard potential probably increases when these 
chemicals occur in combination with each other; having exposure to chemicals with the same 
functional alpha-diketone group and effect on the same system or organ (e.g., lungs) can 
result in additive effects [ACGIH 2017a]. The NIOSH REL is higher for 2,3-pentanedione 
than for diacetyl largely because analytic measures were not available in a validated OSHA 
method to detect 2,3-pentanedione at lower levels. In addition to the REL, NIOSH also 
recommends an action level for diacetyl of 2.6 ppb to be used with exposure monitoring in an 
effort to ensure employee exposures are routinely below the diacetyl REL. When exposures 
exceed the action level, employers should take corrective action (i.e., determine the source of 
exposure, identify methods for controlling exposure) to ensure that exposures are maintained 
below the NIOSH REL for diacetyl [NIOSH 2016].
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Table 1. Personal exposure limits for compounds sampled for during the NIOSH survey, 
April 2016.
OSHA* ACGIH NIOSH
Compound
PEL TLV STEL REL STEL IDLH
Diacetyl — 10 ppb 20 ppb 5.0 ppb† 25 ppb —
2,3-Pentanedione — — — 9.3 ppb† 31 ppb —
2,3-Hexanedione — — — — — —
Carbon dioxide§ 5,000 ppm 5,000 ppm 30,000 ppm 5,000 ppm 30,000 ppm
40,000 
ppm
Carbon 
monoxide§ 50 ppm 25 ppm — 35 ppm 200 ppm (ceiling limit)¶ 1,200 ppm
Note: OSHA=Occupational Safety and Health Administration; ACGIH=American Conference of 
Governmental Industrial Hygienist; NIOSH=National Institute for Occupational Safety and Health; 
PEL=permissible exposure limit; TLV=threshold limit value; STEL=short-term exposure limit; 
REL=recommended exposure limit; IDLH=immediately dangerous to life or health; ppb=parts per 
billion; ppm=parts per million; “—“=no exposure limit available. 
*There are no OSHA STELs for the compounds in the table.
†The NIOSH RELs for diacetyl and 2,3-pentanedione are time-weighted averages for up to 8-hour day, 
during a 40-hour workweek.
§OSHA and NIOSH limits are designed for occupational exposure measurements in manufacturing and 
other trades that have potential sources of carbon dioxide or carbon monoxide (e.g., welding, vehicle 
exhaust, diesel engine exhaust). Typical levels of carbon monoxide in offices are 0–5 ppm. In office 
settings, carbon dioxide generally should not be greater than 700 ppm above outdoor carbon dioxide 
levels; this typically corresponds to indoor concentrations below 1200 ppm. 
¶This is the NIOSH ceiling exposure limit for carbon monoxide. A ceiling concentration should not be 
exceeded at any time.
Obliterative Bronchiolitis
Obliterative bronchiolitis is a serious, often disabling, lung disease that involves scarring 
of the very small airways (i.e., bronchioles). Symptoms of this disease can include cough, 
shortness of breath on exertion, and/or wheeze, that do not typically improve away from 
work [NIOSH 2012]. Occupational obliterative bronchiolitis has been identified in flavoring 
manufacturing workers and microwave popcorn workers who worked with flavoring 
chemicals or butter flavorings [Kreiss 2013; Kim et al. 2010; Kanwal et al. 2006]. It has 
also been identified in employees at a coffee processing facility that produced unflavored 
and flavored coffee [CDC 2013]. A NIOSH health hazard evaluation at that facility found 
diacetyl and 2,3-pentanedione concentrations in the air that were concerning and identified 
three sources: 1) flavoring chemicals added to roasted coffee beans in the flavoring area; 2) 
grinding unflavored roasted coffee beans and packaging unflavored ground and whole bean 
roasted coffee in a distinct area of the facility, and 3) storing roasted coffee in hoppers, on 
a mezzanine above the grinding/packaging process, to off-gas [Duling et al. 2016]. At the 
time of the health hazard evaluation, workers had excess shortness of breath and obstruction 
on spirometry, both consistent with undiagnosed lung disease. Respiratory illness was 
associated with exposure and not limited to the flavoring areas [Bailey et al. 2015]. However, 
all workers who were diagnosed with obliterative bronchiolitis had worked in the flavoring 
area. To date, no cases of obliterative bronchiolitis have been reported in workers at coffee 
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roasting and packaging facilities that produce only unflavored coffee.
Work-related Asthma
Work-related asthma refers to asthma brought on by (“occupational asthma”) or made worse 
by (“work-exacerbated asthma” or “work-aggravated asthma”) workplace exposures [Tarlo 
2016; Tarlo and Lemiere 2014; OSHA 2014; Henneberger et al. 2011]. It includes asthma 
due to sensitizers, which cause disease through immune (allergic) mechanisms, and asthma 
due to irritants, which cause disease through non-immune mechanisms. Symptoms of work-
related asthma include episodic shortness of breath, cough, wheeze, and chest tightness. The 
symptoms may begin early in a work shift, towards the end of a shift, or hours after a shift. 
They generally improve or remit during periods away from work, such as on weekends or 
holidays. 
Green and roasted coffee dust and castor beans (from cross-contamination of bags used to 
transport coffee) are known risk factors for occupational asthma [Figley and Rawling 1950; 
Karr et al. 1978; Zuskin et al. 1979, 1985; Thomas 1991]. Persons who become sensitized 
(develop an immune reaction) to coffee dust can subsequently react to relatively low 
concentrations in the air. Others can experience irritant-type symptoms from exposure to 
coffee dust [Oldenburg et al. 2009].
Previous Industrial Hygiene Sampling at This Coffee Processing Facility
On September 23, 2015, an industrial hygiene contractor collected area and TWA personal air 
samples in the roasting and grinding areas. Personal full-shift samples were collected from 
two employees who roasted coffee (roasters) and one employee who ground and packaged 
coffee. In addition to the TWA sampling, short-term (15 minute) personal samples were 
collected during specific tasks. According to the industrial hygiene report dated October 21, 
2015, all sample results were above the NIOSH REL of 5 ppb [NIOSH 2016] and the ACGIH 
TLV of 10 ppb [ACGIH 2016] for diacetyl. TWA exposures for the three personal samples 
ranged from 48 ppb–94 ppb. The NIOSH STEL is 25 ppb for diacetyl [NIOSH 2016] and the 
ACGIH TLV-STEL is 20 ppb [ACGIH 2016]. The STEL is a 15-minute TWA exposure that 
should not be exceeded at any time during a workday. Two short-term (15 minute) samples 
were collected during roasting and grinding activities. The STEL result collected on a roaster 
was 98 ppb and the grinder result was 46 ppb, both above the NIOSH and ACGIH STELs.
Based on these air sampling results, the coffee roasting and packaging company wanted to 
be proactive and more fully characterize concentrations of alpha-diketones in the air and 
assess the efficiency of the existing ventilation systems. In October 2015, the management 
submitted a health hazard evaluation request to NIOSH.
Process Description
The facility was approximately 70,000 square feet with 45,000 square feet dedicated to 
production activities. At the time of the NIOSH visit in April 2016, approximately 60 
employees were located at the main location. The production activities were performed by 
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approximately 20 employees and supported by three quality control laboratory employees. 
Production activities occurred over two shifts in a 5-day workweek with most employees 
working 8-hour shifts. The remaining employees were involved in administrative tasks 
including accounts receivable, customer service, inventory control, graphic design, sales, 
community outreach, and farmer relations. In addition to the main location, an additional 30 
employees had relocated to an offsite facility in the spring of 2015. At this site, distribution 
activities for finished goods including coffee and chocolate products were performed 
by approximately 12 warehouse employees while the remaining employees performed 
administrative tasks in office settings.
Green coffee beans were received in burlap or jute bags from 13 countries. After arrival in 
the facility’s receiving area, pallets of bagged beans were stored by origin and lot in the green 
coffee bean storage area until needed in the roasting area. In preparation for roasting, burlap 
bags were cut open and green beans emptied into a feed hopper. From the feed hopper, the 
beans were conveyed into a shaker and magnetic separator where they underwent cleaning 
before being pneumatically transferred into one of eight storage silos; total silo capacity was 
approximately 32,000 pounds of beans. 
To prepare a batch for roasting, green coffee beans were pneumatically fed into a roaster 
feed hopper and automatically inducted into the roaster barrel on either one of two natural 
gas fired (convection) roasters. The Probat R-1000 roaster is capable of roasting 440 pounds 
of green beans while the Probat G-120 roaster can accommodate 230 pounds. Batches were 
automatically pulled from a single silo or more than one silo if a blend of beans was to be 
roasted. The beans were heated at a specific temperature and for a precise time to achieve the 
desired roast profile. Types of roasts offered included medium, Full City, Vienna, or French 
roasts. At the end of each roast cycle, the roasted beans were automatically water quenched 
inside the roaster barrel to initiate the cooling process before being automatically transferred 
into the enclosed cooling bin for mechanical mixing by an agitator to accelerate cooling. The 
enclosed cooling bin used an up-draft exhaust system that pushed air up from the bottom 
of the bin, over the roasted beans, and out the roof-top exhaust. Exhaust from each roasting 
barrel and cooling tray/bin flowed through a particulate cyclone and thermal oxidizer. Once 
the roasted beans were cooled, the roaster operator collected a sample for quality control 
checks. Quality control checks involved grinding a small amount of roasted beans and 
testing the roast color profile using a color analyzer. The beans were then transferred through 
a pneumatic destoner into either a rolling tote or supersack (large industrial sized bag). A 
roaster operator monitored the roasting equipment carefully throughout the roasting and 
cooling process. Containers with roasted beans were then moved to the off-gassing, blending, 
grinding, or packaging areas. 
Routine cleaning activities were employed at both roasters. Chaff from the destoner trays 
was emptied daily. The roaster operator used a shovel to clean out the chaff barrel from the 
roaster cyclone and transferred chaff from the barrel into large plastic bags that were donated 
to local farmers. For the R1000 roaster, a thermal clean-out was initiated every 80 hours. 
This 1.5-hour automated process involved running the roaster at high temperatures to remove 
buildup of organic material from the inside of the emission pipes. All emissions were routed 
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through the thermal oxidizer as in normal roasting. For the G120 roaster, a manual cleaning 
process was initiated every 500 hours. This process involved removing emission piping from 
the machine and cleaning any organic buildup inside the emission pipes.
Unlined supersacks were staged in the off-gassing area for a period of 24 hours–48 hours. 
Roasted whole coffee beans were fed into hoppers and transferred through a conveyance 
blender to feed the 5 pound packaging line. In the grinding area, a production employee used 
a hoist to raise roasted whole bean supersacks to the top of the grinder hopper. The supersack 
was then manually untied, and the roasted beans were gravity-fed into the grinder. Typical 
batch sizes were approximately 400 pounds. The grinder could be adjusted for type of grind 
(coarse, medium, or fine). Ground coffee was collected in another supersack attached to the 
discharge chute. At times during grinding, the employee manually collected a sample of the 
ground coffee at the discharge chute. Once grinding was completed, a production employee 
moved the supersack to its applicable packaging line.
In addition to the large capacity production grinder, two small table-top grinders accessible 
to all employees were located just inside the production area. These grinders were used at 
various times throughout the day for personal use.
Roasted whole bean and ground coffee were packaged on one of four automated packaging 
lines. All packages were flushed with nitrogen before filling to ensure freshness. On the can 
line, whole bean and ground coffee were packaged in 14 ounce fully-recyclable cans. These 
cans featured a foil lid fitted with a one-way valve. This line was staffed by four production 
assistants and an employee to palletize finished product. Ground coffee was processed on the 
can line approximately twice a month. Whole bean coffee was packaged in 5 pound bags that 
were fitted with one-way valves and heat-sealed. Two 5 pound bags were packed into each 
cardboard box by a production assistant. Whole bean and ground coffee were packaged into 
both 10 ounce and 12 ounce bags fitted with one-way valves and heat-sealed. Once packaged, 
bags were packed into cardboard boxes. Ground coffee previously off-gassed for a minimum 
of 48 hours was packaged into 1.5, 2.25, 2.5, 7.0, or 8 ounce packages on the pillow pack 
line for use in commercial 12 cup or 1.5 gallon brewers. After filling, these packs were 
heat-sealed and packaged into cases. In addition to the automated packaging lines, a hand 
packaging station was used to package whole bean and ground coffee in smaller quantities 
via a weigh-fill machine.
Each packaging line was monitored by production assistants to assure quality of packaging. 
In the event of packaging defects, some re-work of product was required. Re-work involved 
manually cutting open defective packaging, emptying coffee into a plastic container, and 
then returning coffee to the supply hopper on the appropriate packaging line. After individual 
packages were filled, they were heat sealed, packaged and palletized, and moved via forklift 
to a staging area for transfer to the offsite warehouse.
There was a small maintenance area with one designated employee responsible for 
maintenance of production equipment.
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The primary purpose of the quality control laboratory, located across from the loading 
docks and the staging area, was to ensure the quality of the coffee produced at the facility. 
Coffee quality was evaluated daily by a process called cupping, where quality control staff, 
purchasers, and production roasters smelled, tasted, and assigned scores to coffee brewed 
from samples of roasted beans. The roasted beans used for cupping came from three sources: 
coffee bean samples from farmers (pre-ship), purchased coffee beans shipped to the facility 
(arrival), and beans roasted at the facility (production). The quality control laboratory 
completed three to four cuppings per day. Cuppings were prepared by roasting coffee beans, 
grinding roasted beans, and brewing. The cupping process takes approximately one hour 
depending on the types of beans being evaluated (i.e., pre-ship, arrival, or production).
 
In addition to cupping, the quality control staff also graded green coffee beans, roasted coffee 
bean samples, conducted triangulations used to certify and grade tasters, analyzed brewed 
coffee, and tested packaging. All procedures in the quality control laboratory were performed 
in accordance with standards and protocols set by the Specialty Coffee Association of 
America.
Various cleaning techniques were used throughout production areas. Cleaning methods 
used for the production area and equipment included sweeping (dry and wet), wiping (dry 
and wet cloths), and using compressed air. Employees used brooms to routinely sweep the 
production floor and once a week used a floor scrubber. They used wet or dry wipes on table 
tops and equipment surfaces and compressed air to remove coffee bean dust from surfaces 
and equipment. 
Employees were not required to wear a company uniform or protective clothing. Upon 
entry into the production area employees were required to wear a hair net or hat. Hearing 
protection was recommended for the roasting and grinding areas. Some employees were 
observed using hearing protection. Voluntary use of N95 filtering facepiece respirators was 
reported. 
Methods
We visited the coffee processing facility in April 2016. We performed the industrial 
hygiene survey during April 18–22, 2016. On the first day, we held an opening meeting 
with management and employee representatives from all work areas to explain the health 
hazard evaluation process and to describe the sampling procedures. For part of the first 
day, we were joined by representatives from the Massachusetts Department of Public 
Health. During the remainder of the week, we performed a ventilation assessment in 
the production area, collected air samples, and collected bulk samples of roasted coffee. 
We also toured the warehouse location where finished product was stored before being 
shipped. At the conclusion of the industrial hygiene survey, we held a brief closing meeting 
with management and employee representatives. The medical survey was performed 
during April 25–29, 2016. We provided a letter detailing our evaluations and preliminary 
recommendations to management on May 10, 2016.
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We had the following objectives for the health hazard evaluation: 
1. Measure employees’ exposure to diacetyl, 2,3-pentanedione, and 2,3-hexanedione 
during coffee processing;
2. Identify process areas or work tasks associated with elevated levels of diacetyl, 
2,3-pentanedione, and 2,3-hexanedione;
3. Measure levels of CO and CO2 in areas of the facility;
4. Measure CO levels in employees’ exhaled breath;
5. Assess ventilation systems and their effect on exposure levels;
6. Determine if employees had mucous membrane, respiratory, or systemic symptoms, 
and the proportion of those symptoms that were work-related or aggravated by work;
7. Determine if employees had abnormal lung function tests; 
8. Compare employees’ prevalence of lower respiratory symptoms and healthcare 
provider-diagnosed asthma with expected levels based on general population values.
Industrial Hygiene Survey
Sampling Times for Alpha-Diketones 
We designed the sampling strategy to assess full-shift exposures and identify tasks and 
processes that were the greatest contributors to worker exposure to alpha-diketones. For 
diacetyl, 2,3-pentanedione, and 2,3-hexanedione, air samples were collected over seconds, 
minutes, and hours. Samples collected over hours can help determine average concentrations 
that can be compared with the NIOSH RELs for diacetyl and 2,3-pentanedione. These 
average concentrations might not tell us about short-term peak exposures that could be 
relevant to respiratory health, particularly when tasks are repeated multiple times per day. 
Therefore, during particular tasks, we collected air samples over several minutes. When the 
samples were equal to 15 minutes, we also conducted instantaneous sampling over seconds to 
help identify point sources of alpha-diketones
Employees who participated in air sampling were given the opportunity to request their 
individual air sampling results
Air Sampling and Analysis Using Occupational Safety and Health Administration (OSHA) 
Methods 1013/1016
We collected personal and area air samples for diacetyl, 2,3-pentanedione, and 
2,3-hexanedione on silica gel sorbent tubes. The samples were collected and analyzed 
according to the modified OSHA sampling and analytical Methods 1013/1016 [OSHA 2008; 
OSHA 2010; LeBouf and Simmons 2017]. In accordance with the two methods, two glass 
silica gel sorbent tubes were connected by a piece of tubing and inserted into a protective, 
light-blocking cover. The tubes were connected in series to a sampling pump pulling air 
through the tubes at a flow rate of 50 milliliters per minute (mL/min). The sampling setup 
was attached to an employee’s breathing zone or placed in an area basket in various places 
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throughout the facility. For full-shift personal sampling, we collected two consecutive 3-hour 
samples and calculated the TWA concentration from the two samples, assuming the total 
6-hour monitoring results reflected a full work shift (8-hour) TWA exposure. Although this 
might introduce some error, it is a conservative approach more protective of employees than 
the alternative assumption of no exposure during the last two hours of the shift. We refer to 
these samples as “full-shift samples” throughout this report. Area samples on the first three 
days of sampling were collected using three consecutive 3-hour samples and on the fourth 
day of sampling two consecutive 3-hour samples were collected. We also collected short-
term, task-based samples during specific work tasks (e.g., roasting, grinding, packaging) 
with a sampling pump flow rate of 200 mL/min as detailed in OSHA Methods 1013 and 
1016 [OSHA 2008; 2010]. Sampling times were dependent on the duration of the task being 
performed. 
Analyses of the samples were performed in the NIOSH Respiratory Health Division’s 
Organics Laboratory. The samples were extracted for one hour in 95% ethanol:5% water 
containing 3-pentanone as an internal standard. Samples were analyzed using an Agilent 
7890/7001 gas chromatograph/mass spectrometer system operated in selected ion monitoring 
mode for increased sensitivity compared to the traditional flame ionization detector used in 
OSHA Methods 1013 and 1016 [LeBouf and Simmons 2017].
A limit of detection (LOD) is the lowest mass an instrument can detect above background 
and is a criteria used to determine whether to report a result from a sample. The limit of 
quantitation (LOQ) is the lowest mass that can be reported with precision; we have a greater 
confidence in the reported result if above the LOQ. The samples were analyzed using 
two instruments. The LODs were 0.005 micrograms per sample (µg/sample) for diacetyl, 
2,3-pentanedione, and 2,3-hexanedione on instrument A. For a typical full-shift air sample, 
these equate to 0.32 ppb for diacetyl, 2,3-pentanedione, and 2,3-hexanedione. The LODs for 
the instrument B were 0.005 µg/sample for diacetyl, 0.006 µg/sample for 2,3-pentanedione, 
and 0.01 µg/sample for 2,3-hexanedione. For a typical full-shift air sample, these equate 
to 0.32 ppb for diacetyl, 0.33 ppb for 2,3-pentanedione, and 0.48 for 2,3-hexanedione. The 
LODs for task samples vary because of differing air volumes collected while sampling 
specific tasks and are higher than typical LOD values for full-shift samples. When the 
values presented in the report are from samples below the LOD they are denoted by a “<” 
symbol. The LOQs for instrument A equate to 1.1 ppb for diacetyl, 2,3pentanedione, and 
2,3-hexanedione. The LOQs for instrument B equate to 1.05 ppb for diacetyl, 1.08 for 
2,3-pentanedione, and 1.59 for 2,3-hexanedione instrument B for a typical full-shift air 
sample.
Air Sampling and Analysis Using Evacuated Canisters
In addition to OSHA’s sampling methods for diacetyl and 2,3-pentanedione, NIOSH has 
also been using evacuated canisters [LeBouf et al. 2012] with flow controllers to collect air 
samples for diacetyl, 2,3-pentanedione, and 2,3-hexanedione in workplaces.
We collected instantaneous task-based and source air samples for VOCs including diacetyl, 
2,3-pentanedione, and 2,3-hexanedione using evacuated canisters. We also collected 
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instantaneous air samples before and after the work shift to determine if air concentrations of 
alpha-diketones varied over a work shift. The evacuated canister sampling setup consisted of 
a 450-mL evacuated canister equipped with an instantaneous flow controller designed for a 
short sampling duration (less than 30 seconds). Instantaneous samples were taken by opening 
the evacuated canister to grab a sample of air. For task-based air samples, a NIOSH employee 
placed the inlet of the flow controller by the employee’s personal breathing zone as they 
performed their work task to replicate exposure. For source air samples, a NIOSH employee 
placed the inlet of the flow controller directly at the source of interest.
The canister air samples were analyzed using a pre-concentrator/gas chromatograph/
mass spectrometer system pursuant to a published method validation study [LeBouf 
et al. 2012], with the following modifications: the pre-concentrator was a Model 7200 
(Entech Instruments, Inc., Simi Valley, CA), and six additional compounds (diacetyl, 
2,3-pentanedione, and 2,3-hexanedione, acetaldehyde, acetonitrile, and styrene) were 
included. At present, this canister method is partially validated [LeBouf et al. 2012] and 
not considered the standard method. The LODs were 0.39 ppb for diacetyl, 0.54 ppb for 
2,3-pentanedione, and 0.96 ppb for 2,3-hexanedione. However, LODs are dependent on the 
pressure inside each canister after samples have been collected and they might be higher or 
lower than typical LOD values.
Bulk Sampling and Headspace Analysis
We used 50-mL sterile polypropylene centrifuge tubes to collect approximately 40-mL 
bulk samples of roasted coffees (whole bean and ground). For headspace analysis of alpha-
diketones, we transferred 1 gram of solid bulk material bulk material into a sealed 40-mL 
amber volatile organic analysis vial and let it rest for 24 hours at room temperature (70°F) 
in the laboratory. Then 2 mL of headspace air was transferred to a 450-mL canister and 
pressurized to approximately 1.5 times atmospheric pressure. Using the canister analysis 
system, the concentrations were calculated in ppb of analytes in the headspace as an indicator 
of emission potential. 
Real-time Air Sampling
We used RAE Systems (San Jose, CA) ppbRAE 3000 (Model #PGM-7340) monitors to 
measure levels of total volatile organic compounds (TVOCs) in the air. The ppbRAE has a 
non-specific photoionization detector that responds to chemicals with ionization potentials 
below the energy of the lamp. This sampling was conducted to identify areas where coffee 
could be releasing VOCs. Areas with higher release of VOCs can be targets for sampling for 
alpha-diketones and for exposure controls. We also collected real-time measurements of CO2, 
CO, temperature, and relative humidity (RH) in various locations using TSI Incorporated 
(Shoreview, MN) VelociCalc Model 9555-X Multi-Function Ventilation Meters equipped 
with Model 982 IAQ probes.
Exhaled CO Measurements
We asked employees to perform a carboxyhemoglobin (COHb) test one or more times 
throughout their shift to measure CO levels in their exhaled breath. This test helps determine 
if employees are exposed to elevated levels of CO. Employees were asked to hold their 
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breath for 15 seconds and then exhale through a mouthpiece into a CO monitor. The device 
then calculated an estimate of COHb in blood. We asked participants when they last smoked 
cigarettes or used tobacco products. Tobacco smoke from cigarettes, cigars, and pipe tobacco 
contains CO and can cause an increase in exhaled CO. Employees who participated in COHb 
testing were mailed their individual test results.
Ventilation Assessment
We completed visual and physical assessments of all ventilation components at the facility. 
Physical measurements were taken with a Model DISTO E7100i laser-tape measure (Leica 
Geosystems AG, Heerbrugg, Switzerland). Because of the height, configuration, and large 
airflow rate of the two makeup air units used to supply fresh air in the production area 
space, we did not have equipment that allowed for ventilation measurements. However, 
we collected information on existing ventilation equipment, including make, model, and 
specified performance levels. Differential pressure measurements between adjacent spaces 
were taken under various ventilation scenarios using an Energy Conservatory (Minneapolis, 
MN) DG-500 Pressure Gauge.
NIOSH Medical Survey
Participants                                                                                                                                          
We invited all current employees to participate in the medical survey at the workplace during 
April 25–29, 2016. Participation was voluntary; written informed consent was obtained 
from each participant before testing. An interpreter was used during the medical survey for 
non-English speaking employees. The survey included, in the order performed, a medical 
and work history questionnaire, quantification of exhaled nitric oxide, impulse oscillometry, 
spirometry, and if indicated the administration of a bronchodilator with repeat impulse 
oscillometry and spirometry. We mailed participants their individual reports explaining their 
breathing test results and recommended each participant provide the information to their 
personal physician. 
Questionnaire  
We used an interviewer-administered computerized questionnaire to ascertain symptoms 
and diagnoses, work history at this coffee roasting and packaging facility and other coffee 
or flavoring companies, and cigarette smoking history. Questions on respiratory health were 
derived from five standardized questionnaires, the European Community Respiratory Health 
Survey [Burney et al. 1994; ECRHS 2014], the American Thoracic Society adult respiratory 
questionnaire (ATS-DLD-78) [Ferris 1978], the International Union Against Tuberculosis 
and Lung Disease [Burney et al. 1987, 1989], and the Third National Health and Nutrition 
Examination Survey (NHANES III) [CDC 1996] and NHANES 2007–2012 questionnaires 
[CDC 2018]. Some of the questions appeared on more than one of the standardized 
questionnaires. We also supplemented our questionnaire with additional respiratory and 
systemic symptom questions. 
Spirometry 
The purpose of the spirometry test was to determine a person’s ability to move air out of their 
lungs. Test results were compared with expected normal values. The test included the three 
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measurements or calculations: 1) forced vital capacity (FVC) (the total amount of air the 
participant can forcefully blow out after taking a deep breath), 2) 1-second forced expiratory 
volume (FEV1) (the amount of air that the participant can blow out in the first second of 
exhaling), and 4) the calculation of the ratio of FEV1 to FVC. We used American Thoracic 
Society criteria for acceptability and repeatability [Miller et al. 2005]. 
We used a volume spirometer (dry rolling seal spirometer) to measure exhaled air volume 
and flow rates. We used equations for predicted values and lower limits of normal derived 
from NHANES III data to define abnormal spirometry [Hankinson et al. 1999]. We defined 
obstruction as an FEV1/ FVC ratio less than the lower limit of normal with FEV1 less than the 
lower limit of normal; restriction as a normal FEV1/FVC ratio with FVC less than the lower 
limit of normal; and mixed obstruction and restriction as having FEV1, FVC, and FEV1/FVC 
ratio all less than the lower limit of normal. We used the FEV1 percent predicted to categorize 
such abnormalities as mild, moderate, moderately severe, severe, or very severe [Pellegrino 
et al. 2005]. 
Impulse Oscillometry
Many occupational lung diseases (e.g., chronic obstructive pulmonary disease (COPD), 
asthma) involve the small airways; however, this part of the lung is difficult to evaluate non-
invasively. Oscillometry is a helpful technology to understand the effects of occupational 
exposures on the small airways. There are no contraindications to the test as this test is 
conducted using regular breathing and does not require a forceful exhalation [Smith et al. 
2005]. Spirometry can be normal despite respiratory symptoms or evidence of small airways 
disease on lung biopsy [King et al. 2011; Oppenheimer et al. 2007]; therefore, oscillometry 
results complement spirometry and can be used when spirometry is not possible because of a 
contraindication.
We used an impulse oscillometry machine (CareFusion Corp., San Diego, CA) to measure 
resistance (R), the energy required to propagate the pressure wave through the airways, 
and reactance (X), which reflects the viscoelastic properties of the respiratory system. The 
impulse oscillometry testing machine sends sound waves called pressure oscillations at 
different frequencies (e.g., 5 Hertz and 20 Hertz) into the airways to measure how airways 
respond to these small pressures. The test calculates 1) the airway resistance at different 
frequencies including 5 Hertz (R5) and 20 Hertz (R20), and the difference between R5 
and R20 (DR5-R20); 2) the reactance at different frequencies including 5 Hertz (X5); 3) 
resonance frequency (Fres) which is the frequency where there is no airway reactance; and 
4) the total reactance (AX) at all frequencies between 5 Hertz and the Fres. The predicted 
values for R and X were based on sex and age according to references values recommended 
by the manufacturer [Vogel and Smidt 1994]. R5 was considered abnormal (elevated) if 
the measured value was equal to or greater than 140 percent of the predicted R5. X5 was 
considered abnormal (decreased) if the value of the predicted X5 minus measured X5 was 
equal to or greater than 0.15 kilopascals per liter per second (kPa/(L/s)) DR5-R20 values 
greater than 30% were considered abnormal and evidence of frequency dependence [Smith 
2015]. We interpreted the test as normal if both the R5 and X5 were normal [Smith 2015]. 
We defined possible large (central) airways abnormality as a normal X5 and elevated R5 
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with no evidence of frequency dependence. We defined a possible small airways abnormality 
if there was evidence of frequency dependence and/or a decreased X5 with or without an 
elevated R5. We defined possible combined small (peripheral) and large (central airways) 
abnormality as a decreased X5 and elevated R5 with no evidence of frequency dependence.
Bronchodilator Reversibility Testing for Impulse Oscillometry and Spirometry
If a participant had abnormal impulse oscillometry or spirometry, we repeated both tests after 
the participant received a bronchodilator inhaler medication (i.e., albuterol), which can open 
the airways in some individuals (e.g., asthmatics). For oscillometry, we defined reversibility 
(improvement) after bronchodilator administration as a decrease of at least 20% of either Fres 
or R5 or a decrease of 40% for AX. For spirometry, we defined reversibility (improvement) 
as increases of at least 12% and 200 mL for either FEV1 or FVC after bronchodilator 
administration. 
 
Fractional Exhaled Nitric Oxide (FeNO) 
We used the NIOX MINO® device (Aerocrine Inc., Morrisville, NC) to measure the amount 
of nitric oxide in the air the participant breathed out. Nitric oxide is a gas that is produced by 
the airways, and elevated levels can be a sign of eosinophilic airway inflammation in asthma 
[Dweik et al. 2011]. In adults, fractional nitric oxide concentration in exhaled breath levels 
above 50 ppb are considered elevated. In adults with asthma, elevated levels may indicate 
that their asthma is uncontrolled [Dweik et al. 2011].
Statistical Analysis 
Industrial Hygiene Survey and Ventilation Assessment
We performed analyses using Excel (Microsoft®, Redmond, WA) and SAS version 9.3 (SAS 
Institute, Cary, NC). When the values presented in the report are from samples below the 
LOD they are denoted by a “<” symbol.
 
Medical Survey
We calculated frequencies and standardized morbidity ratios (SMRs) and their associated 
95% confidence intervals (CIs) using SAS version 9.3 (Cary, NC). The SMRs compare 
prevalences of symptoms and spirometric abnormalities among participants with expected 
prevalences of a sample of the general population reflected in the NHANES III (1988–1994, 
symptom data) and NHANES 2007–2012 (symptom data) adjusting for sex, race/ethnicity, 
age (less than 40 years old or 40 years or greater), and cigarette smoking categories (ever/
never). For comparisons with the U.S. population, we used the most recent NHANES survey 
available for the specific comparisons. 
Results
All results tables are located in Appendix A.
Industrial Hygiene Survey
Personal and Area Full-shift Air Sampling Results
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OSHA Methods 1013/1016
Table A1 presents the personal and area full-shift air sampling results. Twenty-seven 
employees participated in the personal sampling. We collected 88 personal and 96 area 
full-shift samples. Four of the area samples were collected outside the facility. Sixty-nine 
(78%) of 88 personal air samples exceeded the NIOSH REL for diacetyl of 5.0 ppb. Workers 
performing duties in grinding, packaging, roasting, and in the general production area had 
full-shift samples that exceeded the NIOSH REL for diacetyl the majority of the time. Seven 
of 88 personal air samples (8%) exceeded the NIOSH REL for 2,3-pentanedione of 9.3 ppb. 
Eighty-four of 88 personal air samples (95%) had 2,3-hexanedione concentrations below the 
analytical method LOD. The maximum concentration of 2,3-hexanedione measured was 0.3 
ppb. 
Overall, employees in packaging had the highest average personal exposure to diacetyl of 
13.2 ppb (range for 38 samples: 1.6 ppb–25.6 ppb). Thirty-seven (97%) of the 38 full-shift 
personal samples on packaging employees exceeded the NIOSH REL for diacetyl by as 
much as five times. The only full-shift personal sample below the NIOSH REL for diacetyl 
was 1.6 ppb on an employee working the can line. There was no obvious reason for this 
result to differ from the other samples. Employees in roasting had the second highest average 
personal exposure to diacetyl of 13.1 ppb. Ten of the 11 roaster employee measurements 
(91%) exceeded the NIOSH REL for diacetyl (range: 4.4 ppb–19.2 ppb). All of the full-
shift personal samples on an employee in grinding (range for 4 samples: 10.3 ppb–13.8 
ppb) exceeded the NIOSH REL for diacetyl. Full-shift samples for diacetyl for employees 
performing duties in the production area including maintenance and forklift/receiving (4 
samples) ranged from 5.0 ppb–10.4 ppb; quality control laboratory (12 samples) ranged from 
1.9 ppb–16.8 ppb; and production offices including production supervisor (9 samples) ranged 
from 1.4 ppb–8.1 ppb. Personal full-shift measurements were lowest on employees at the 
front desk (2 samples) and in 2nd floor offices (5 samples) ranging from 0.5 ppb–4.04 ppb; all 
were below the NIOSH REL for diacetyl.
Seven of the 88 full-shift personal samples (8%) exceeded the NIOSH REL of 9.3 ppb for 
2,3-pentanedione. Samples exceeding the REL included four collected on employees in 
packaging, two in roasting, and one in the quality control laboratory. Almost all (85/88) of 
the full-shift personal samples results for 2,3-hexanedione were below the method LOD. 
Area samples were collected in 20 locations throughout the facility. The highest full-shift 
area samples were collected in grinding (ranges for eight samples: 12.0 ppb–68.9 ppb for 
diacetyl and 5.2 ppb–31.4 ppb for 2,3-pentanedione). The roasting area had the second 
highest levels of diacetyl and 2,3-pentanedione (ranges for 12 samples: 7.5 ppb–37.8 ppb 
for diacetyl and 3.7 ppb–23.0 ppb for 2,3-pentanedione). The packaging area had the third 
highest levels of diacetyl ranging from 5.9 ppb–21.6 ppb and 2,3-pentanedione ranging from 
2.3 ppb–17.1 ppb. Within packaging, the pillow line sample had the highest concentrations 
of diacetyl (21.6 ppb) and 2,3-pentanedione (17.1 ppb). The quality control laboratory area 
samples ranged from 7.7 ppb–11.7 ppb for diacetyl. Samples within the general production 
area ranged from 1.3 ppb–13.5 ppb for diacetyl. The general production area sample 
collected in the finished product shelving had the highest concentrations of diacetyl (range: 
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9.1 ppb–13.5 ppb) while the general production area sample collected at the loading dock 
had the lowest concentration of diacetyl (range: 1.3 ppb–7.1 ppb). The area samples collected 
in the kitchen, 2nd floor sales offices, and 2nd floor library had the lowest concentrations of 
diacetyl (range: 0.5 ppb–3.2 ppb) and 2,3-pentanedione (range: <0.2 ppb–1.5 ppb). We note 
NIOSH RELs are intended to be directly compared with personal full-shift measurements; 
therefore, an area air sample exceeding a NIOSH REL is only an indication of potential 
personal exposures.
Task-based Air Sampling Results
OSHA Method 1013/1016
Table A2 presents the personal task-based air concentrations by individual task. Importantly, 
tasks associated with coffee processing are varied and as such the duration also varies. We 
collected 108 personal task-based air samples using OSHA Methods 1013/1016, and the 
sample duration ranged from three minutes–24 minutes. Sixty-two of the tasks sampled 
lasted for 15 minutes, allowing for their results to be compared directly with the NIOSH 
STELs for diacetyl (25 ppb) and 2,3-pentanedione (31 ppb). 
Employees who performed re-work of packaged coffee had the highest exposure to diacetyl 
(range for four samples: 11.9 ppb–69.9 ppb) and 2,3-pentanedione (range: 8.7 ppb–39.2 ppb). 
Each of the four rework task samples lasted 15 minutes, allowing for comparison with the 
NIOSH STELs. Three of the 15-minute samples exceeded the NIOSH STEL for diacetyl, and 
one of the samples exceeded the NIOSH STEL for 2,3-pentandione. Employees who moved 
roasted beans or ground coffee had the second highest exposure to diacetyl (range for four 
samples: 4.5 ppb–56.9 ppb) and 2,3-pentanedione (range: 2.0 ppb–24.4 ppb). Employees that 
ground coffee had the third highest exposure to diacetyl (range for 10 samples: 15.5 ppb–
52.6 ppb). Six of the grinding task samples lasted 15 minutes, and three of these exceeded 
the NIOSH STEL for diacetyl of 25 ppb. Two grinding task samples were collected for 16 
minutes, and their diacetyl concentrations were 31 ppb and 46.8 ppb, both of which are over 
the NIOSH STEL of 25 ppb for diacetyl. No grinding task samples exceeded the STEL for 
2,3-pentanedione. 
There were 39 samples taken during packaging tasks where diacetyl concentrations ranged 
from <0.9 ppb to 42.2 ppb for diacetyl. Five 15-minute samples exceeded the NIOSH STEL 
for diacetyl of 25 ppb. No packaging task samples exceeded the STEL for 2,3-pentanedione. 
One packaging task sample lasted for 14 minutes. When we assume zero exposure for the 
remaining minute of the sample, the calculated concentration exceeds the NIOSH STEL of 
25 ppb for diacetyl. Employees roasting coffee had measured exposures to diacetyl (range 
for 19 samples: 1.7 ppb–32.8 ppb); one 15-minute sample exceeded the NIOSH STEL for 
diacetyl. 
Evacuated Canisters
Instantaneous Canister Task-based sampling Results
Table A3 presents the personal task-based air concentrations from the evacuated canister 
sampling. We collected 36 personal task-based canister air samples. Because of the very short 
duration of the samples, results should not be compared with the 15-minute STELs. 
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The instantaneous task sample collected in the breathing zone of a packaging employee 
while loading ground coffee into a hopper on the pillow pack line had the highest level 
of diacetyl (3,765 ppb) and 2,3-pentanedione (3,377 ppb), and the second highest level 
of 2,3-hexandione (96 ppb). The second highest levels of diacetyl (2,692 ppb) and 
2,3-pentandione (949 ppb) were measured in an instantaneous task sample collected in 
the breathing zone of an employee during the removal of a supersack full of ground coffee 
from the grinder. Other instantaneous task samples collected during tasks associated with 
grinding also had relatively high levels of diacetyl (369–1,279 ppb) and 2,3-pentanedione 
(163–408 ppb). The third highest levels of diacetyl (2,146 ppb) and 2,3-pentanedione (743 
ppb) were observed when an employee dumped French Roast whole beans into a hopper on 
the blending line. The 2,3-hexanedione level of 106 ppb in this sample was the highest of all 
samples.
We collected 17 instantaneous canister samples during a variety of tasks in the quality control 
laboratory including grinding and cupping. Concentrations of diacetyl ranged from 9 ppb–74 
ppb, and 2,3-pentanedione ranged from 7 ppb–44 ppb. 2,3-Hexanedione concentrations were 
lower, ranging from <0.9 ppb–6 ppb. The highest diacetyl and 2,3-pentanedione levels were 
associated with grinding coffee beans.
Thirteen samples were taken during tasks in the roasting area including grinding samples 
of roasted coffee for quality control and checking the roast profile. Diacetyl levels (range: 
18 ppb–98 ppb) and 2,3-pentanedione levels (range: 10 ppb–101 ppb) were higher in 
tasks where an employee ground samples of roasted coffee for quality control checks. 
2,3-Hexanedione levels were less than the analytical method LOD for most samples.
Source Canister Sampling Results
Table A4 presents instantaneous source air sampling results using evacuated canisters. We 
collected 43 source canister air samples. The three samples with the highest concentrations 
of diacetyl, 2,3-pentanedione, and 2,3-hexanedione were all associated with ground coffee. 
The sample with the highest concentrations was collected at a supersack of ground coffee 
on the ICA packaging line 10 minutes after the coffee had been ground (diacetyl 26,406 
ppb, 2,3-pentanedione 13,139 ppb, and 2,3-hexandione 378 ppb). The second highest 
sample concentrations were measured in a sample collected during grinding of a supersack 
of Breakfast Blend (diacetyl 11,160 ppb, 2,3-hexanedione 2739 ppb, and 2,3-hexanedione 
272 ppb). The third highest concentrations were from a sample taken at the opening of 
a supersack in the off-gassing area approximately two hours after the coffee was ground 
(diacetyl 10,541 ppb, 2,3-pentanedione 4,123 ppb, and 2,3-hexanedione 205 ppb). The 
instantaneous source samples collected at the main grinder and at the grinders (sample 
and espresso) in the quality control laboratory tended to have higher concentrations of 
diacetyl, 2,3-pentanedione, and 2,3-hexanedione. A sample taken at the espresso grinder 
had 809 ppb diacetyl, 679 ppb 2,3-pentanedione, and 27 ppb 2,3-hexanedione while a 
sample taken pulling espresso shots had 467 ppb diacetyl, 430 ppb 2,3-pentanedione, and 
17 ppb 2,3-hexanedione. A sample taken on the can packaging line where the beans enter 
the can had 2,086 ppb diacetyl, 823 ppb 2,3-pentanedione, and 83 ppb 2,3-hexanedione. All 
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14 instantaneous source samples collected at the roasters and roaster sample grinders had 
diacetyl and 2,3-pentanedione levels below 100 ppb. 
Background Pre- and Post-Shift Diacetyl and 2,3-Pentanedione Canister Results
Table A5 presents the instantaneous evacuated canister pre- and post-shift background air 
sampling results on Tuesday, April 20, 2016, and Thursday, April 22, 2016. Samples were 
collected in the middle of the production area and between the staging and green bean 
storage areas on both days. Air concentrations of diacetyl and 2,3-pentanedione increased 
over the course of the day on both dates. Both pre- and post-shift concentrations for diacetyl 
and 2,3-pentanedione were higher on April 20 than on April 22 at both sampling locations. 
The pre-shift diacetyl concentration on April 20 in the middle of the production area was 
11.8 ppb, and the post-shift concentration was 25.5 ppb. The pre-shift 2,3-pentanedione 
concentration was 4.2 ppb, and the post-shift concentration was 8.4 ppb. On April 22, the 
pre-shift diacetyl concentration in the middle of the production area was 5.9 ppb, and the 
post-shift concentration was 20.3 ppb. The pre-shift 2,3-pentanedione concentration was 2.0 
ppb, and the post-shift concentration was 7.3 ppb.
The post-shift concentrations of diacetyl and 2,3-pentanedione in the samples collected 
between the staging and green bean storage area were also higher on April 20 than on 
April 22. The pre-shift diacetyl concentration on April 20 was 9.9 ppb, and the post-shift 
concentration was 38.2 ppb. The pre-shift 2,3-pentanedione concentration was 3.5 ppb, and 
the post-shift concentration was 20.1 ppb. On April 22, the pre-shift diacetyl concentration 
between the staging and green bean storage area was 5.6 ppb, and the post-shift concentration 
was 19.3 ppb. The pre-shift 2,3-pentanedione concentration was 2.6 ppb, and the post shift 
concentration was 8.6 ppb. The 2,3-hexanedione concentrations in all samples were always 
less than 2.0 ppb.
Bulk Samples and Headspace Results
Table A6 presents the results from 11 bulk samples of whole bean and ground coffee using 
headspace analysis. There was one sample of ground coffee collected from a supersack on a 
packaging line on April 21, 2016. Each of the five whole bean samples with a corresponding 
ground bean sample were collected on April 22, 2016. Both diacetyl and 2,3-pentanedione 
concentrations were always higher in the whole bean sample than in the ground sample. 
2,3-Pentanedione concentrations were higher than the diacetyl concentrations in both the 
whole bean and ground samples of the dark medium Honduran, medium Mexican, and Full 
City Peru Decaf. 2,3-Hexanedione results were below the method LOD in eight of the 11 
samples. The 2,3-hexanedione concentration (300.8 ppb) in one of three samples with results 
above the LOD was greater than 2,3-pentanedione concentration and similar to the diacetyl 
concentration.
Real-time Monitoring: Temperature, Relative Humidity (RH), Carbon Dioxide (CO2), Carbon 
Monoxide (CO), and Total Volatile Organic Compounds (TVOCs)
During sampling April 19–22, 2016, the outdoor temperatures ranged from 46°F–81°F, and 
the outdoor RH ranged from 25%–87%. Overall temperature and RH ranges in the main 
production area were 63°F–80°F and 18%–48%, respectively. Temperatures in the quality 
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control laboratory were slightly warmer ranging from 74°F–82°F, with RH ranging from 
22%–42%. Temperature and RH in the second floor sales and library area ranged from 
69°F–76°F and 22%–39%, respectively.
Table A7 presents results from real-time monitoring of CO2, CO, TVOCs, temperature and 
relative humidity. Throughout the week of collection, outdoor CO2 levels ranged from 358 
ppm–380 ppm, and outdoor CO levels ranged from 0 ppm–0.3 ppm. Average CO2 levels were 
highest at the roaster sample grinders (794 ppm) and behind the main grinder (770 ppm). 
Average CO (25.7 ppm) was highest to the left of the discharge chute (25.7 ppm) at the main 
grinder and ranged from 1.4 ppm–7.7 ppm in the other locations. Average levels of TVOCs 
were highest to the left of the discharge chute at the main grinder (3,270 ppb) and lowest in 
the off gassing area (735 ppm).
Our real-time monitoring demonstrated the highest peak measurements of CO and CO2 
occurred at the main grinder on the second day of sampling (4/20/2016). On the first day 
of sampling (4/19/2016), the area basket with the monitors at the grinder was located to the 
right of the ground coffee discharge chute next to the grinder control panel. An estimated 
3,850 pounds of coffee was ground, and the average CO concentration was 7.7 ppm, and the 
average CO2 concentration was 596 ppm. We noticed the air was moving across the monitor 
to the left. On the second day of sampling (4/20/2016), we moved the area sampling basket 
to the other side of the grinder so it was positioned to the left of the discharge chute. An 
estimated 3,150 pounds of coffee was ground. The average CO concentration was 25.7 ppm, 
and the average CO2 concentration was 749 ppm. On the third day of sampling (4/21/2016), 
we placed the area sampling basket behind the grinder next to the grinder operator desk. An 
estimated 2,450 pounds of coffee was ground. The average CO concentration was 6.6 ppm, 
and the average CO2 concentration was 770 ppm.
 
Figure 1. Carbon monoxide (CO) and carbon dioxide (CO2) 
concentrations during sampling on April 20, 2016, to the left of the 
discharge chute at the main grinder.
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On April 20, 2016, NIOSH staff recorded activities taking place at the main grinder while 
continuous monitoring devices were recording CO2, CO, and TVOC levels. The area basket 
with the samplers was positioned to the left of the grinder at breathing zone height. Figure 1 
shows the CO2 and CO levels during the sampling period. Each of the peaks corresponds
with times when batches of coffee were being ground. The first peak was generated during 
grinding of approximately 100 pounds. The remaining peaks were associated with grinding 
larger batches. CO2 concentrations ranged from 433 ppm to >5,000 ppm (average 749 ppm), 
and the CO concentrations ranged from 0.8 ppm to >500 ppm (average 25.7). The instrument 
was only capable of recording CO2 up to 5,000 ppm and CO up to 500 ppm. CO2 levels 
exceeded 5,000 ppm twice while CO levels exceeded 500 ppm 36 times. 
The TVOC peaks overlapped with the CO peaks. The average TVOC concentration was 
3,270 ppb with a maximum reading of 71,819 ppb. The maximum reading occurred when a 
supersack of ground coffee was removed from the discharge chute of the grinder, tied closed, 
and moved to the packaging line. 
On April 20, 2016, an area sampler was positioned at the red roaster (Probat G-120). CO 
concentrations ranged from 0 ppm–44 ppm (average 3.9 ppm), and CO2 ranged from 446 
ppm–1,045 ppm (average 666 ppm). 
Figure 2 shows the CO and TVOC concentrations at the red roaster. The average TVOC 
concentration at the red roaster was 1,008 ppb with a maximum reading of 3,066 ppb.
Figure 2. Carbon monoxide (CO) and total volatile organic compound 
(VOC)  concentrations at the red roaster on April 20, 2016.
Figure 3 overlays the CO measurements at the main grinder and the red roaster. The majority 
of the red roaster peaks coincide with the main grinder peaks. Figure 4 overlays the TVOC 
measurements at the main grinder and the red roaster. The TVOC levels at the red roaster 
also correspond with the TVOC levels at the main grinder.
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Figure 3. Carbon monoxide (CO) concentrations at the main grinder and at 
the red roaster on April 20, 2016.
Figure 4. Total volatile organic compound (VOC) concentrations at the 
main grinder and the red roaster on April 20, 2016.
Personal Exhaled Carbon Monoxide (CO) Measurements
Twenty-seven employees provided breath samples for measurement of CO by exhaling into 
a monitor at various times during the workday. Measurements were typically collected at 
the beginning of the shift, lunch break, and at the end of the shift. After exhaling into the 
monitor, the device reported a CO value in ppm and also calculated an estimated COHb 
percentage. The overall average CO level was 2.1 ppm (range: 0 ppm–15 ppm), and COHb 
was 0.8% (0%–3%). Average CO level in smokers was 4.9 ppm (range: 0 ppm–15 ppm), and 
COHb was 1.4% (range: 0%–3%). All COHb test results in non-smokers were below 2.2%, 
and in smokers were below 3%.
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Ventilation Assessment
Two large makeup air units on the roof of the production space were used periodically to 
bring fresh air into the facility. The units were generally turned on during the early mornings 
of our visit, but were turned off for the majority of the days we were onsite. These units 
were reportedly used more in the winter to provide some heat to the facility, and almost 
never during the summer months. Ceiling fans were in use in the production area during our 
sampling.
Differential pressure measurements taken with the rooftop makeup air units off indicated 
the majority of adjacent spaces were generally neutral to the production space. The two 
exceptions were the receiving office and the procurement office, which were both slightly 
positive to production. However, when the makeup air units were on, the majority of adjacent 
spaces were under slightly negative pressure to production (the receiving office and the 
procurement office both remained positive). This means air from the production space can be 
pushed into the negative-pressure adjacent spaces when the makeup air units are operating, at 
least under the conditions when our pressure measurements were taken. The non-production 
spaces of the facility are served by six rooftop air-handling units. Different combinations of 
operating states of those units (i.e., which ones are on and off simultaneously) on the non-
production side of the plant could make the pressure differentials better or worse.
Other Observations
We observed some employees having difficulty untying the closures on the supersacks. 
Although we did not collect task samples during this activity, during these periods, the 
employees had the potential to be exposed to peaks of diacetyl and 2,3-pentanedione while in 
position near the opening of the supersack containing roasted coffee. 
We observed some employees in the roaster and grinder areas wearing hearing protection 
while employees working in close proximity in the packaging areas were not wearing hearing 
protection. Although we did not conduct noise exposure monitoring during our visit, it is 
possible sound levels might exceed the OSHA PELs, the OSHA action level, or the NIOSH 
REL for noise [29 CFR 1910.95; NIOSH 1998]. Noise seemed to be especially loud when the 
grinder, green bean induction hoppers, and roaster destoners were operating simultaneously. 
In our initial interim letter dated May 10, 2016, we recommended an evaluation of noise 
levels to determine if a more formal hearing protection program was necessary.
Medical Survey Results
Demographics
Seventy-nine of 94 onsite employees (84%) participated in the medical survey. Of these, 
26 employees worked at the offsite location. The majority of participants were male (54%) 
and white (67%), with a mean age of 41 years (range 19 years–72 years) and average tenure 
at the company (including previous locations) of eight years (range: 2 months–30 years). 
Thirty-one (39%) participants were current or former smokers. 
Forty-seven (59%) participants reported ever spending time in the production area. Of these; 
18 (38%) spent more than 32 hours per week in the production area. The mean time reported 
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being spent in the production area per week was 16.7 hours (range: 0.1 hours–50 hours). 
Employees reported being within an arm’s length of the following exposures: an operating 
production coffee roaster (n=19, 24%); cooling bins that contain roasted beans while they are 
cooling (n=20, 25%), an operating production grinder (n=19, 24%); and packaging of coffee 
(n=30, 38%). 
Symptoms and Self-Reported Diagnoses
The prevalences of symptoms over the last year and last four weeks at the time of the survey 
are listed in Table A8. Nose symptoms (n=57, 72%) were the most commonly reported, 
followed by eye symptoms (n=43, 54%). Wheeze (n=18, 23%) and breathing trouble (n=18, 
23%) were the most commonly reported lower respiratory symptoms. The prevalence of 
symptoms between participants who reported working at the main facility and the offsite 
location was similar (data not shown). Sixteen (20%) and 11 (14%) participants reported 
their nose and eye symptoms were aggravated by work, respectively. Of the 18 participants 
who reported wheezing, 12 reported their wheezing was the same away from the workplace, 
two reported their wheezing was worse away from the workplace, and four reported their 
wheezing was better away from the workplace. Two of the four participants who reported 
their breathing was better away from the workplace worked in production. Three participants 
reported their breathing trouble was better away from the workplace; one of the three 
participants worked in production. Some production employees noted their nose and sinus 
symptoms were caused or aggravated by green coffee bean dust, chaff, and ground coffee. 
Twenty-two participants reported a diagnosis of hay fever or nasal allergies; among these, 
seven reported the diagnosis was made post-hire. Thirteen participants reported ever having 
received a diagnosis of asthma; two received the diagnosis post-hire. 
The prevalences of symptoms over the last year at the time of the survey for employees who 
reported spending any time in production areas (n=47) and for employees who reported not 
spending any time in production areas (n=32) are listed in Table A9. Overall, the prevalence 
of nose, eye, lower respiratory, and systemic symptoms were comparable between employees 
who reported spending time in production areas and employees who did not spend time in 
production areas.
Medical Tests
Twenty participants had at least one breathing test interpreted as abnormal. Among these, 
four (20%) were current smokers, six (30%) were former smokers, and 11 (55%) reported 
ever working in the production area. No spirometry tests were interpreted as abnormal. Ten 
impulse oscillometry tests were interpreted as consistent with a small airway abnormality, 
two with a large airway abnormality, and three with small and large airway abnormalities. 
Fourteen of the 15 participants with impulse oscillometry tests interpreted as abnormal 
were given bronchodilator, and five had significant improvement in impulse oscillometry. 
Six exhaled nitric oxide tests were interpreted as elevated. Three of the six participants 
with elevated nitric oxide tests reported ever working in production. Two participants with 
abnormal exhaled nitric oxide tests had current asthma. 
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NHANES Comparison of Symptoms, Diagnoses, and Spirometry
The SMRs for stuffy, itchy, or runny nose (SMR=1.3); phlegm production for three 
consecutive months (2.3); wheezing (1.7); ever having received a physician diagnosis of 
asthma (2.2); and currently having a physician diagnosis of asthma (2.6) were elevated (Table 
A10). SMRs for eye symptoms, sinus problems, shortness of breath on exertion, and cough 
were not elevated. 
Discussion
Diacetyl, 2,3-pentanedione, 2,3-hexanedione, other VOCs, and other chemicals such as CO 
and CO2 are naturally produced when coffee beans are roasted, and grinding the roasted 
coffee beans produces greater surface area for the off-gassing of these chemicals [Anderson 
et al. 2003; Akiyama et al. 2003; Daglia et al. 2007; Newton 2002; Nishimura et al. 2003; 
Raffel and Thompson 2013]. Occupational exposure to diacetyl and 2,3-pentanedione can 
cause loss of lung function and the lung disease obliterative bronchiolitis [NIOSH 2016]. 
Alpha-Diketones
Personal Air Sampling
Average air concentrations of diacetyl and 2,3-pentanedione in this facility were compared 
with their respective NIOSH RELs of 5.0 ppb and 9.3 ppb. The majority (78%) of personal 
full-shift diacetyl exposures were above the NIOSH REL of 5.0 ppb, and 88% were above 
the NIOSH AL for diacetyl of 2.6 ppb. The highest average personal exposures to diacetyl 
were in packaging employees (13.2 ppb), roasting employees (13.1 ppb), and an employee 
performing grinding (11.8 ppb). Eighteen of 28 (64%) full-shift samples on employees 
performing duties in the general production area, production office, and quality control 
laboratory also had results that exceeded the REL for diacetyl. Eight percent of the personal 
full-shift samples were above the NIOSH REL of 9.3 ppb for 2,3-pentanedione. These seven 
personal full-shift samples were collected on employees in roasting (two samples), the 
quality control laboratory (one sample), and on the packaging lines (four samples). Personal 
full-shift samples from employees in the second floor offices and at the front desk did not 
exceed either REL.
As noted earlier, the REL should be used as a guideline to indicate when steps should be 
taken to reduce exposures in the workplace. The risks associated with the measured levels 
are higher than NIOSH recommends. As described in the quantitative risk assessment 
from the NIOSH Criteria Document (Table 5-27) [NIOSH 2016], after a 45-year working 
lifetime exposure to 20 ppb (a concentration lower than the highest concentration (26 ppb) 
measured at this facility), NIOSH estimated that 3 in 1,000 workers would develop reduced 
lung function (FEV1 below the 5th percentile). NIOSH predicted that around 5 in 10,000 
workers exposed to diacetyl at 20 ppb would develop more severe lung function reduction 
(FEV1 below 60% predicted, defined as at least moderately severe by the American Thoracic 
Society [Pellegrino et al. 2005]). After a 45-year working lifetime exposure to 50 ppb (a 
concentration higher than the highest concentration measured at this facility), NIOSH 
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estimated that 8 in 1,000 workers would develop reduced lung function (FEV1 below the 5th 
percentile). NIOSH predicted that 12 in 10,000 workers exposed to diacetyl at 50 ppb would 
develop more severe lung function reduction. The effects of a working lifetime exposure at 
26 ppb would be between those for 20 ppb and 50 ppb. NIOSH recommends keeping diacetyl 
concentrations below 5 ppb because at this level, the risk of reduced lung function after a 
working lifetime of exposure is below 1 in 1000 workers. NIOSH recommends taking steps 
to reduce diacetyl exposures to below the REL of 5 ppb whenever possible.
Area Air Sampling
The highest area samples for diacetyl and 2,3-pentanedione were in the grinding, roasting, 
and packaging areas. Although lower, diacetyl and 2,3-pentandione concentrations in eight 
other locations within the production area and in the quality control laboratory were also 
elevated. The area samples collected in the kitchen area and second floor offices and library 
space had the lowest concentrations. Of the 96 full-shift area samples, 76 (79%) were above 
the NIOSH REL for diacetyl and 12 (13%) above the REL for 2,3-pentanedione. We note 
NIOSH RELs are intended for personal full-shift measurements; however full-shift area air 
samples exceeding the RELs can be an indicator for areas with potential personal exposures. 
Overall, 2,3-hexanedione concentrations were low with only four personal and three area 
samples results above the LOD.
Task-Based Exposures
Coffee processing involves multiple tasks that can cause intermittent exposure to diacetyl and 
2,3-pentanedione. Traditional full-shift sampling will not characterize these intermittent peak 
exposures. Evaluating intermittent and task-based exposures to diacetyl and 2,3-pentanedione 
is difficult with current validated sampling methods (OSHA Methods 1013/1016). Because 
tasks are sporadic in coffee processing, with some only lasting a few seconds or minutes, 
we used instantaneous evacuated canisters to sample tasks that lasted only a few seconds to 
minutes and OSHA Methods 1013/1016 for longer duration tasks. We sampled by task, with 
varying durations, to understand which tasks might have contributed to higher exposures to 
diacetyl and 2,3-pentanedione.
Sixty-two samples with a duration of 15-minutes were compared with the NIOSH STELs 
for diacetyl (25 ppb) and 2,3-pentanedione (31 ppb) (Table A2). Rework of packaged coffee 
had the highest exposure with three of the four samples exceeding the diacetyl STEL and 
one exceeding the 2,3-pentanedione STEL. Three task samples taken during grinding, five 
samples during coffee packaging, and one sample during roasting, exceeded the diacetyl 
STEL. 
We also used instantaneous evacuated canisters to sample tasks with short duration. 
These samples were collected by placing the inlet of the canister near the breathing zone 
of an employee while they performed a task. Four of the highest instantaneous sample 
results for both diacetyl and 2,3-pentanedione were associated with ground coffee (Table 
A3). Loading ground coffee into a hopper on the pillow pack line in packaging had the 
highest concentration of diacetyl (3,765 ppb) and 2,3-pentandione (3,377 ppb). Removing 
supersacks of ground coffee from the grinder and sealing the supersack resulted in diacetyl 
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concentrations of 369 ppb to 2,692 ppb and 2,3-pentanedione of 163ppb to 949 ppb. The 
greater surface area created from grinding might have contributed to these concentrations 
[Akiyama et al. 2003]. Concentrations of diacetyl (2,146 pbb) and 2,3-pentanedione (743 
ppb) were measured while dumping whole bean roasted coffee into a hopper along the 
blending line. This sample also had the highest measured concentration of 2,3-hexanedione 
of 106 ppb.
 
In addition to tasks, we used evacuated canisters to collect samples at specific point-
sources (Table A4). For these samples, the inlet of the flow controller was placed directly 
at the source of interest. As with the task-based samples, the diacetyl and 2,3-pentanedione 
concentrations were highest at sources where ground coffee was present. The highest sample 
for diacetyl (26,406 ppb) and 2,3-pentanedione (13,139 ppb) was measured at a supersack 
of freshly ground coffee on the ICA packaging line. Seven samples collected at the grinder 
had diacetyl concentrations ranging from 15.4 ppb–11,160 ppb and 2,3-pentanedione 
concentrations from 7.8 ppb–2,739 ppb. In the QC laboratory, the highest concentrations 
were also measured at the espresso grinder while pulling shots of espresso.
Instantaneous samples collected at the beginning of production and at the end of production 
in the same two locations on April 20, 2016, and April 22, 2016, demonstrated the 
concentrations of diacetyl, 2,3-pentanedione and 2,3-hexanedione increased throughout the 
day (Table A5). This indicates that the generation rate of these compounds exceeded the rate 
at which existing ventilation systems removed them under the conditions when samples were 
taken. 
Bulk Samples
Diacetyl isn’t found in green beans and forms later in the coffee roasting process [Daglia 
et al. 2007]. We observed higher levels of diacetyl and 2,3-pentanedione in the whole bean 
samples than in the ground samples. Normally, we would expect ground coffee to provide 
higher levels of alpha-diketones than whole bean coffee. Thus, our observation may be the 
result of the bulk samples sitting in sealed tubes for several weeks prior to opening the tubes 
and manipulating the samples for analysis. 
Real-time Monitoring: Carbon Dioxide (CO2), Carbon Monoxide (CO), and Total Volatile 
Organic Compounds (TVOCs)
The real-time monitoring demonstrated that the highest peak measurements of CO, CO2, and 
TVOCs occurred to the left of the main grinder discharge chute while grinding was taking 
place. One employee had primary responsibility for all activities associated with grinding. 
We noted no employees spent long periods of time standing near the grinder discharge chute 
during the sampling period. No employees had elevated COHb test results. The location of 
the main grinder may allow for contaminants to be shared with other areas including roasting 
and packaging.
The roaster barrel burner intakes and the afterburner intakes for the roasters might be pulling 
contaminants from grinding toward the roasting area as illustrated by examining the real-
time monitoring results for CO and total VOC concentrations (Figures 5 & 6) at the main 
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grinder and red roaster on April 20, 2016. The peaks at the red roaster trend with the peaks at 
the main grinder. The same trends were evident on the following day when we examined the 
real-time monitoring results from the main grinder and from the sample grinder in roasting. 
Ventilation
As shown in Table A5, concentrations of alpha-diketones increased in the production area 
throughout the course of the day indicating these compounds were being generated faster 
than they could be removed by existing ventilation systems. We also determined air from the 
production areas could potentially enter non-production areas under the conditions of testing, 
particularly when the make-up air units were on. The operational state of various air-handling 
units and make-up air units throughout the facility could make pressure differentials better 
or worse. Loading dock doors being opened or closed will also effect pressure differentials. 
Constant negative pressure in the production area relative to non-production areas is needed 
to keep contaminants from the production space from migrating to non-production areas. To 
maintain consistent negative pressure in the production area, additional exhaust systems are 
needed. These systems could consist of local exhaust at contaminant sources, general exhaust 
fans through the walls or ceiling, or a combination of both.
Local exhaust ventilation
Local exhaust ventilation systems capture contaminants when generated and exhausts them 
before inhalation by employees occurs. Local exhaust ventilation systems generally consist 
of hoods or enclosures, duct work, or fans. Depending on the contaminant and whether air 
is recirculated, filters or other air cleaning technologies can be incorporated. When properly 
designed local exhaust ventilation systems are installed, overall workplace exposure levels 
can be reduced by removing contaminants at the source. High concentrations of alpha-
diketones were measured at the main grinder, at the opening of supersacks, on the can line 
in packaging, and at the espresso machine in the quality control laboratory.  Work with a 
ventilation engineer to reduce alpha-diketone exposures in these locations. If exposure levels 
are still elevated after modifications have been made, it may be necessary to perform further 
sampling to identify additional point sources. 
General exhaust or dilution ventilation
In an ideal environment, good general ventilation provides fresh air into the space and 
removes contaminated air. General exhaust ventilation allows contaminants to be emitted into 
the workplace and then dilutes the concentration of the contaminant to acceptable levels. This 
is generally done by providing fresh outdoor air (or recirculated, filtered air) to the space to 
provide dilution. Simultaneously, air is exhausted from the space to remove the contaminants. 
The relationship between supply air and exhaust air flow rates can be used to help maintain 
appropriate pressure relationships. If more air is supplied than exhausted, the space will 
generally be under positive pressure, which allows contaminants to migrate from the space to 
adjacent areas. Conversely, exhausting more air than is supplied, maintains the space under 
negative pressure which helps contain the contaminants in the area where they are generated. 
During the April 2016 survey, two make-up air units capable of supplying fresh air to 
the production space were present. The systems were reportedly operated intermittently 
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and seasonally, and used more in winter to provide heat. Operating the makeup air units 
consistently would help to dilute airborne concentrations of alpha-diketones, but most 
likely would not maintain concentrations below the NIOSH RELs for diacetyl and 
2,3-pentanedione. Air was only being exhausted from the production area via the roasters, 
and the quantity of air exhausted was variable depending on the operating condition of each 
roaster. If more air was exhausted, through new wall or ceiling-mounted exhaust fans, it 
would help reduce concentrations of diacetyl and 2,3-pentanedione in the production space.  
It would also aid in keeping the production area under negative pressure compared with the 
non-production areas, which is desirable. 
 
Relocation or enclosure of specific processes
While engineering controls are undoubtedly needed to reduce exposures, relocating processes 
or specific pieces of equipment to make control implementation easier might also reduce 
worker exposures. On April 20, 2016, we measured total VOCs at both the main grinder 
and the red roaster (Figure 6). It was clear any contaminant generation at the grinder was 
simultaneously detected at the red roaster. This demonstrates the roasters’ exhaust pulls 
contaminants generated during grinding toward that corner of the production area. Thus, 
roaster operators are likely exposed to alpha-diketone concentrations from processes other 
than roasting. Isolating the grinder in conjunction with local exhaust ventilation would likely 
reduce overall alpha-diketone exposures to employees in the production area. While it would 
be difficult to enclose the grinder in its current location, moving the grinder closer to an 
exterior wall could make it easier to enclose the grinding process and reduce costs associated 
with ventilating the process separately. Other process areas such as blending and off-gassing 
might be candidates for enclosure with separate ventilation to further reduce concentrations 
of alpha-diketones in the production area. 
In general, the current ventilation configuration in the production area should be evaluated. 
An evaluation by a qualified ventilation engineer can determine if modifications to existing 
ventilation components could be made to lower airborne concentrations and/or whether 
the installation of new equipment may be necessary. In addition to dilution ventilation, 
the installation and use of local exhaust ventilation systems to decrease concentrations of 
diacetyl and 2,3-pentanedione can be explored, and an overall, cost-effective solution can 
be developed. After making changes to production ventilation, processes, controls, or work 
practices additional air sampling should be conducted to determine the effect on exposure 
conditions within the workplace.
Medical Survey 
Overall, nose and eye symptoms were the most commonly reported symptoms. Some 
employees reported their nose and sinus symptoms were caused or aggravated by green 
coffee dust, chaff, or roasted coffee dust. Coffee dust is an organic dust and, as noted earlier, 
exposure to coffee dust is known to cause respiratory symptoms and a known risk factor for 
occupational asthma [Karr et al. 1978; Zuskin et al. 1979, 1985, 1993; Thomas et al. 1991; 
Sakwari et al. 2013].
Upper respiratory diseases such as allergic rhinitis (hay fever, nasal allergies) and sinusitis 
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are sometimes associated with lower respiratory symptoms and asthma, and can precede the 
diagnosis of asthma [Shaaban et al. 2008; EAACI Task Force on Occupational Rhinitis et 
al. 2008; Rondón et al. 2012, 2017; Sahay et al. 2016]. Upper respiratory involvement (e.g., 
rhinitis, sinusitis) can result in suboptimal control of asthma. Thirty-two (84%) of the 38 
participants who reported lower respiratory symptoms also reported nasal or sinus problems 
or physician-diagnosed hay fever or nasal allergies.
Green coffee dust is thought to be a more potent allergen than roasted coffee dust because 
roasting destroys some of the allergenic activity [Lehrer et al. 1978]. As discussed in the 
recommendation section, to prevent symptoms related to green coffee dust, make N95 
disposable filtering facepiece respirators available for voluntary use for protection against 
dust exposure such as when emptying burlap bags of green beans into the storage silos feed 
hopper, cleaning the exhaust system of chaff, emptying the chaff containers, or cleaning the 
green bean storage area.
The number of participants with current physician-diagnosed asthma was approximately 
2.5 times higher than that observed in the U.S. population. Asthma symptoms often 
improve when away from exposures that trigger symptoms while other lung diseases such 
as obliterative bronchiolitis or chronic obstructive pulmonary disease (COPD) generally 
do not improve. Spirometry can be used to help detect and follow individuals with asthma 
and other lung diseases such as obliterative bronchiolitis or COPD. Spirometry can show if 
air is exhaled from the lungs more slowly than normal (i.e., obstructive abnormality) or if 
the amount of air exhaled is smaller than normal (i.e., restrictive abnormality). In asthma, 
there is intermittent airways obstruction that is reversible after treatment with bronchodilator 
medications (e.g., albuterol). In obliterative bronchiolitis, scar tissue prevents the small 
airways (bronchioles) from opening up when albuterol is given. In other words, the airways 
obstruction is fixed and not responsive (reversible) to bronchodilator medicine. The 
obstructed airways prevent rapid emptying of the lung air sacs (alveoli) during exhalation. 
This explains why the respiratory symptoms of those with occupational obliterative 
bronchiolitis do not tend to improve when away from work-related exposures; however, 
avoidance of further exposure can stop progression of the disease [Akpinar-Elci et al 2004]. 
Spirometry and impulse oscillometry measure different things. Spirometry assesses airflow 
while impulse oscillometry accesses the airways response to a sound or pressure wave. In 
general, during the impulse oscillometry test, a small pressure impulse (sound wave) is 
imposed upon the inspiratory and expiratory airflow during normal tidal breathing. This 
pressure wave causes a disturbance in the airflow and pressure, and the response of the 
airways (i.e., change in pressure to change in flow) is a measure of the resistance to airflow in 
the airways [Desiraju and Agrawal 2016]. Impulse oscillometry can be useful as an indirect 
measure of airflow obstruction and helpful in individuals not able to perform forced breathing 
maneuvers required during the spirometry test. The impulse oscillometry test has been used 
for many years to measure changes in the airways of children with lung problems such as 
asthma and cystic fibrosis [Song et al. 2008; Komarow et al. 2011; Shi et al. 2012; Schulze et 
al. 2016]. More recently, impulse oscillometry has been used to investigate lung problems in 
adults exposed to dust or chemicals, such as World Trade Center emergency responders and 
Page 31Health Hazard Evaluation Report 2016-0012-3302
soldiers returning from deployment overseas [Oppenheimer et al. 2007; Berger et al. 2013; 
Weinstein et al. 2016]. Over the years, researchers have developed reference (predictive) 
equations for different populations of children for oscillometry [Malmberg et al. 2002; Park 
et al. 2011; Lee et al. 2012; de Assumpcão et al. 2016]. For adults, fewer reference equations 
are available for oscillometry [Vogel and Smidt 1994; Newbury et al. 2008; Schulz et al. 
2013]. The predicted values we used for oscillometry measures were based on gender and 
age according to references values recommended by the manufacturer. Unlike predictive 
equations used for spirometry, the impulse oscillometry reference equations we used did not 
take into account height, race, or smoking status [Vogel and Smidt 1994].
Our findings of upper and lower respiratory symptoms with a work-related pattern in some 
employees, an approximately two-fold excess of wheeze and phlegm production, and 
abnormalities on breathing tests in about 20% of participants suggest a burden of respiratory 
problems in this workforce. Work-related symptoms, which are symptoms that tend to 
improve away from the workplace, might reflect effects of workplace exposures that are 
reversible. However, some participants with lower respiratory symptoms such as wheeze did 
not have a work-related pattern. However, even symptoms that do not improve away from 
the workplace can be related to workplace exposures. In such cases, effects of workplace 
exposures might not be readily reversible, so the pattern of improvement away from the 
workplace is not seen and the recognition of an occupational cause can be delayed. The lower 
respiratory symptoms and the lung function abnormalities we found are not specific to a 
particular respiratory problem or disease. They could be related to workplace exposures or to 
other factors. Indeed, some employees had respiratory diagnoses that preceded employment 
at this facility. We mailed each participant their individual lung function test results with an 
explanation of the results and recommended each participant provide the information to their 
personal physician.
We recommend starting a medical monitoring program because air sampling in the main 
facility detected concentrations of diacetyl and 2,3-pentanedione above the NIOSH RELs, 
and participants were nearly two times as likely to have wheeze and over 2.5 times as likely 
to have current physician-diagnosed asthma compared with the general population. All 
production and quality control laboratory employees and any employees that assist with 
production tasks (e.g., roasting, interacting with open storage bins/containers of roasted 
coffee, grinding, weighing, or packaging coffee) should participate in the workplace medical 
monitoring program. A medical monitoring program is a means of early identification of 
employees who might be developing lung disease (e.g., asthma, obliterative bronchiolitis) 
and can help prioritize interventions to prevent occupational lung disease. The NIOSH 
medical survey results can serve as a baseline for employees who participated. In a 
workplace with risk of occupational lung disease, prevention of smoking-related lung disease 
is important and makes the detection of work-related adverse effects easier. The Centers for 
Disease Control and Prevention offers tools and resources for setting up a smoking cessation 
program [CDC 2017].
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Conclusions
Full-shift personal and area air concentrations of diacetyl exceeded the NIOSH RELs in 
many areas of the facility, particularly in the packaging, grinding, and roasting. Some 
personal samples in the production office and quality control laboratory also exceeded the 
REL for diacetyl. Although fewer in number, some of the sample results also exceeded 
the REL for 2,3-pentanedione. We identified specific work tasks that resulted in air 
concentrations of diacetyl and 2,3-pentanedione that exceeded the NIOSH REL and STEL 
including re-work of packaged coffee, moving roasted whole bean or ground coffee, 
and grinding coffee. The use of real-time instruments demonstrated that the roasters 
may be pulling air from the grinder area which contains higher levels of diacetyl and 
2,3-pentanedione. Over the course of the work day, air concentrations increased within the 
general production area indicating that the current ventilation isn’t sufficient to remove the 
compounds being generated. Some recommendations are being provided to aid in reducing 
exposures and protecting respiratory health.
Overall, mucous membrane symptoms, specifically eye, nose, and sinus symptoms, were 
the most commonly reported symptoms. Some production employees reported their mucous 
membrane symptoms were caused or aggravated by green coffee dust or chaff, roasted 
coffee, or ground coffee dust. Wheezing or whistling in the chest and breathing trouble were 
the most commonly reported lower respiratory symptoms. A statistically significant two-
fold excess of phlegm production, wheezing, having ever received a physician diagnosis of 
asthma, and current physician diagnosis of asthma existed in the participants compared with 
the U.S. noninstitutionalized population of the same age, race/ethnicity, sex, and cigarette 
smoking distribution. No employees had abnormal spirometry results. We recommend 
a medical monitoring program to identify any employees who might be developing 
lung disease (e.g., asthma, obliterative bronchiolitis) and to help management prioritize 
interventions to prevent occupational lung disease. All production workers and employees 
that assist with production and quality control tasks (e.g., roasting, interacting with open 
storage bins/containers of roasted coffee, grinding, weighing, or packaging coffee) should 
participate in the workplace medical monitoring program.
Recommendations 
On the basis of our findings, we recommend the actions listed below. We encourage this 
coffee processing facility to use a labor-management health and safety committee or working 
group to discuss our recommendations and develop an action plan. Our recommendations 
are based on an approach known as the hierarchy of controls. This approach groups actions 
by their likely effectiveness in reducing or removing hazards. In most cases, the preferred 
approach is to eliminate hazardous materials or processes and install engineering controls to 
reduce exposure or shield employees. 
Engineering Controls
Engineering controls reduce employees’ exposures by removing the hazard from the process 
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or by placing a barrier between the hazard and the employee. Engineering controls protect 
employees effectively without placing primary responsibility of implementation on the 
employee. 
1. Work with a ventilation engineer to ensure the production area is maintained under 
negative pressure compared with non-production spaces.
a. Keep all doors between the production and non-production areas closed at all 
times. The air-handling units serving the non-production areas might need to be 
re-balanced to maintain the non-production areas under positive pressure. This 
will prevent contaminant migration from the production area.
b. Ideally, the quality control laboratory should be maintained under negative 
pressure compared with the non-production areas but under positive pressure 
compared with the production area. This is applicable when the existing exhaust 
fan over the sample roasters is on or off.
2. Consider options for isolating the grinder to reduce overall alpha-diketone exposures 
in the production area. Moving the grinder closer to an exterior wall could make it 
easier to enclose the grinding process and reduce costs associated with ventilating 
the process separately. Other process areas such as blending and off-gassing might be 
candidates for enclosure with separate ventilation to further reduce concentrations of 
alpha-diketones in the production area.
3. Install local exhaust ventilation at point sources releasing the highest concentrations 
of alpha-diketones. Areas for consideration include at the main grinder, at the opening 
of supersacks, on the can line in packaging, and at the espresso machine in the quality 
control laboratory. In some cases, moving processes or equipment can make using 
local exhaust ventilation easier and more cost effective. A ventilation engineer can help 
with these decisions and verify the effectiveness of controls after implementation. 
Administrative Controls
Administrative controls are employer-dictated work practices and policies implemented 
to reduce or prevent hazardous exposures. Their effectiveness depends on employer 
commitment and employee acceptance. Regular monitoring and reinforcement are necessary 
to ensure policies and procedures are followed consistently.
1. Limit the amount of time non-production employees spend in the production area to 
the extent possible.
2. To reduce exposures to VOCs (including alpha-diketones), CO and CO2, minimize 
production tasks that require employees to place their heads near sources of roasted 
or ground coffee beans. Tying and untying supersacks presents the opportunity for 
short-term exposure to high concentrations of diacetyl and 2,3-pentanedione. Train 
employees on the proper technique for closure and opening of the supersacks.
3. After engineering controls have been installed, conduct personal air monitoring for 
diacetyl and 2,3-pentanedione on employees with primary duties in the production 
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area. Because air levels of VOCs like diacetyl and 2,3-pentanedione can fluctuate from 
day to day based on production schedules, we recommend personal air sampling for 
diacetyl and 2,3-pentanedione over multiple days.
4. Consider conducting air sampling at the off-site warehouse where finished product is 
stored to determine if there are exposures above the NIOSH RELs.
5. Ensure employees understand potential hazards (e.g., diacetyl, 2,3-pentanedione, 
CO, CO2, green bean and roasted coffee dust) in the workplace and how to protect 
themselves. OSHA’s Hazard Communication Standard, also known as the “Right to 
Know Law” [29 CFR 1910.1200] requires that employees are informed and trained 
on potential work hazards and associated safe practices, procedures, and protective 
measures. Written information should be provided in the languages spoken by 
employees to ensure comprehension of the information.
6. Avoid the use of compressed air as much as possible during cleaning. Instead, use a 
vacuum system with a high-efficiency particle air filter and wet methods whenever 
possible. 
7. Ensure employees are educated to consider the risks of further exposure if they 
develop lower respiratory symptoms (e.g., cough, shortness of breath, wheezing) that 
are progressive and severe. Employees should report new, persistent, or worsening 
symptoms to their personal healthcare providers and to a designated individual at this 
workplace. Employees with new, persistent, or worsening symptoms should share this 
report with their healthcare providers.
Personal Protective Equipment
Personal protective equipment in the form of respiratory protection is considered the least 
effective means for controlling hazardous respiratory exposures because breakdowns in 
implementation can result in insufficient protection. Proper use of respiratory protection 
(respirators) requires a comprehensive respiratory protection program and a high level of 
employee and management involvement and commitment to assure that the right type of 
respirator is chosen for each hazard, respirators fit users and are maintained in good working 
order, and respirators are worn when they are needed. Supporting programs such as training, 
change-out schedules, and medical assessment might be necessary. Respirators should not be 
the sole method for controlling hazardous inhalation exposures. Rather, respirators should be 
used until effective engineering and administrative controls are in place. 
1. In addition to engineering and administrative controls, respiratory protection is a 
potential option to further reduce exposures to alpha-diketones (e.g., diacetyl and 
2,3-pentanedione). If follow-up air sampling after engineering controls have been 
installed indicates levels of diacetyl and 2,3-pentanedione above their respective 
NIOSH RELs and STELs, we recommend that respiratory protection be used during 
tasks with elevated exposures. Respirators used to reduce exposures to diacetyl 
and 2,3-pentanedione should be NIOSH-certified and equipped with organic vapor 
cartridges. The choice of respirator should be guided by personal exposure sampling 
for diacetyl and 2,3-pentanedione (NIOSH 2004). For reference, air-purifying half-
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face respirators have an assigned protection factor (APF) of 10, and air-purifying 
full-face respirators have an APF of 50. Also, there are powered-air purifying 
respirators that have APFs of 25, 50, or 1000. A respirator’s APF refers to the maximal 
level of protectiveness a specific respirator design can achieve under laboratory 
conditions. The OSHA APFs can be found in Table 1 of OSHA Respiratory Protection 
Standard at https://www.osha.gov/pls/oshaweb/owadisp.show_document?p_
table=STANDARDS&p_id=12716. 
If respiratory protection is used, a written respiratory protection program should 
be implemented as required by the OSHA Respiratory Protection Standard (29 
CFR 1910.134), including training, fit testing, maintenance and use requirements.
2. Offer employees the voluntary use of N95 disposable filtering facepiece respirators 
when working with green coffee beans and chaff such as emptying burlap bags of 
green beans into the storage silos feed hopper, when cleaning the exhaust system 
of chaff, when emptying the chaff containers, or cleaning the green bean storage 
area. A written respiratory protection program is not required for voluntary use of 
N95 disposable filtering facepiece respirators. However, N95 respirators should 
be available in various sizes, and each potential N95 user should receive a copy of 
Appendix D of the OSHA Respiratory Protection Standard (http://www.osha.gov/pls/
oshaweb/owadisp.show_document?p_table=standards&p_id=9784). Information about 
Appendix D and voluntary use of respirators can be found on the OSHA website at 
https://www.osha.gov/video/respiratory_protection/voluntaryuse_transcript.html.
Please be aware that N95s are not protective against alpha-diketones (diacetyl, 
2,3-pentanedione, or 2,3-hexanedione). In cases of dual exposure to dust and 
alpha-diketones, NIOSH-certified organic vapor cartridges (for the alpha-
diketones) and particulate cartridges/filters (for the dust) would be warranted.
3. We did not formally assess noise during our visit. A noise survey would be necessary 
to determine the need for hearing protection and inclusion in a hearing conversation 
program. In the interim, continue to offer hearing protection for voluntary use. 
Medical Monitoring
The purpose of a medical monitoring program is to help assure the health of employees 
who have workplace exposures (e.g., diacetyl, 2,3-pentanedione, green coffee beans/dust) 
known to pose risk for potentially serious health conditions such as asthma or obliterative 
bronchiolitis. 
1. Institute a medical monitoring program for employees who work or assist in the 
production area and in the quality control laboratory. The medical monitoring should 
consist of evaluation with a questionnaire (to obtain health and work task information) 
and spirometry (to assess lung function) at baseline and at one year to monitor for 
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respiratory symptoms and to establish employees’ baseline in lung function and 
any abnormal decline in lung function in the first year. Subsequently, an annual 
questionnaire evaluation should occur to monitor for respiratory symptoms. New 
or worsening respiratory symptoms should prompt additional evaluation including 
spirometry. Details about spirometry and a medical monitoring program can be found 
in chapter 9 of the NIOSH Criteria Document [NIOSH 2016].
2. If an employee is identified as likely having lung disease from exposure to diacetyl or 
2,3-pentanedione, it should be viewed as a sentinel event indicating that there was a 
breakdown in exposure controls and that there is potential risk for co-workers. Should 
this occur, the unanticipated source of exposure must be identified and brought under 
control. In addition, increased intensity of medical surveillance would be required for 
all employees performing similar job tasks or having similar or greater potential for 
exposure. The NIOSH Criteria Document provides detailed guidance on responses to 
such sentinel events [NIOSH 2016]. 
Smoking Cessation Program
In a workplace with risk of occupational lung disease, prevention of smoking-related lung 
disease is important and makes the detection of work-related adverse effects easier. We 
recommend implementing a smoking cessation program to assist employees to stop smoking. 
The Centers for Disease Control and Prevention offers tools and resources for setting up a 
smoking cessation program [CDC 2017].
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Table A1. OSHA Methods 1013/1016 full-shift personal and area air sampling results by location, NIOSH 
industrial hygiene survey, April 2016
Analyte Sample Type Location N
Above
LOD
N (%)
Minimum
Concentration
(ppb)
Maximum
Concentration
(ppb)
Above
REL
N
Diacetyl Personal 2nd Floor Offices 5 5 (100%) 1.1 4.0 0
Diacetyl Personal Front Desk 2 2 (100%) 0.5 0.8 0
Diacetyl Personal Grinding 4 4 (100%) 10.3 13.8 4
Diacetyl Personal Packaging — 5LB Bag Line 4 4 (100%) 11.2 17.4 4
Diacetyl Personal Packaging — Can Line 20 20 (100%) 1.6 20.1 19
Diacetyl Personal Packaging — ICA Line 8 8 (100%) 11.0 21.5 8
Diacetyl Personal Packaging — Pillow Line 6 6 (100%) 6.0 25.6 6
Diacetyl Personal Production Area 7 7 (100%) 5.0 10.4 6
Diacetyl Personal Production Office 9 9 (100%) 1.4 8.1 3
Diacetyl Personal Quality Control Laboratory 12 12 (100%) 1.9 16.8 9
Diacetyl Personal Roasting 11 11 (100%) 4.4 19.2 10
Diacetyl Area Grinding 8 8 (100%) 12.0 68.9 N/A
Diacetyl Area 2nd Floor Sales Office 4 4 (100%) 1.3 2.6 N/A
Diacetyl Area 2nd Floor Library 4 4 (100%) 1.4 3.2 N/A
Diacetyl Area Kitchen 4 4 (100%) 0.5 3.0 N/A
Diacetyl Area Blending 4 4 (100%) 13.5 16.1 N/A
Diacetyl Area Packaging — 5LB Bag Line 4 4 (100%) 8.4 11.2 N/A
Diacetyl Area Packaging — Can Line 4 4 (100%) 5.9 11.5 N/A
Diacetyl Area Packaging — ICA Line 4 4 (100%) 9.6 19.6 N/A
Diacetyl Area Packaging — Pillow Line 4 4 (100%) 10.6 21.6 N/A
Diacetyl Area Off-gas 4 4 (100%) 9.1 12.4 N/A
Diacetyl Area Finished Product Racks 4 4 (100%) 9.1 13.5 N/A
Diacetyl Area Finished Products Storage 4 4 (100%) 8.2 11.4 N/A
Diacetyl Area Front Corner in Production 4 4 (100%) 4.6 8.2 N/A
Diacetyl Area Green Bean Storage 4 4 (100%) 8.0 12.3 N/A
Diacetyl Area Loading Docks 4 4 (100%) 1.3 7.1 N/A
Diacetyl Area Production Office 4 4 (100%) 6.8 9.1 N/A
Diacetyl Area Small Personal Grinders 4 4 (100%) 8.5 11.2 N/A
Diacetyl Area Staging Area 4 4 (100%) 8.3 10.6 N/A
Diacetyl Area Quality Control Laboratory 4 4 (100%) 7.7 11.7 N/A
Diacetyl Area Roasting 12 12 (100%) 7.5 37.8 N/A
Diacetyl Area Outside 4 0 (0%) < 0.3 < 0.3 N/A
2,3-Pentanedione Personal 2nd Floor Offices 5 5 (100%) 0.4 2.5 0
2,3-Pentanedione Personal Front Desk 2 1 (50%) <  0.3 0.5 0
2,3-Pentanedione Personal Grinding 4 4 (100%) 4.7 6.7 0
2,3-Pentanedione Personal Packaging — 5LB Bag Line 4 4 (100%) 5.0 9.3 0
2,3-Pentanedione Personal Packaging — Can Line 20 20 (100%) 4.6 9.6 1
2,3-Pentanedione Personal Packaging — ICA Line 8 8 (100%) 5.2 11.4 2
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Analyte Sample Type Location N
Above
LOD
N (%)
Minimum
Concentration
(ppb)
Maximum
Concentration
(ppb)
Above
REL
N
2,3-Pentanedione Personal Packaging — Pillow Line 6 6 (100%) 3.4 15.8 1
2,3-Pentanedione Personal Production Area 7 7 (100%) 2.1 5.1 0
2,3-Pentanedione Personal Production Office 9 9 (100%) 0.6 5.1 0
2,3-Pentanedione Personal Quality Control Laboratory 12 12 (100%) 0.9 10.8 1
2,3-Pentanedione Personal Roasting 11 11 (100%) 2.7 10.2 2
2,3-Pentanedione Area Grinding 8 8 (100%) 5.2 31.4 N/A
2,3-Pentanedione Area 2nd Floor Sales Office 4 4 (100%) 0.7 1.3 N/A
2,3-Pentanedione Area 2nd Floor Library 4 3 (75%) < 0.2 1.5 N/A
2,3-Pentanedione Area Kitchen 4 4 (100%) 0.3 1.5 N/A
2,3-Pentanedione Area Blending 4 4 (100%) 6.3 8.3 N/A
2,3-Pentanedione Area Packaging — 5LB Line 4 4 (100%) 4.3 6.4 N/A
2,3-Pentanedione Area Packaging — Can Line 4 4 (100%) 2.3 6.3 N/A
2,3-Pentanedione Area Packaging — ICA Line 4 4 (100%) 4.8 10.2 N/A
2,3-Pentanedione Area Packaging — Pillow Line 4 4 (100%) 5.3 17.1 N/A
2,3-Pentanedione Area Off-gas 4 4 (100%) 4.6 7.3 N/A
2,3-Pentanedione Area Finished Product Racks 4 4 (100%) 4.4 7.7 N/A
2,3-Pentanedione Area Finished Products Storage 4 4 (100%) 4.3 6.9 N/A
2,3-Pentanedione Area Front Corner in Production 4 4 (100%) 2.4 3.7 N/A
2,3-Pentanedione Area Green Bean Storage 4 4 (100%) 4.2 7.1 N/A
2,3-Pentanedione Area Loading Docks 4 4 (100%) 1.1 2.7 N/A
2,3-Pentanedione Area Production Office 4 4 (100%) 3.3 5.1 N/A
2,3-Pentanedione Area Small Personal Grinders 4 4 (100%) 4.5 5.9 N/A
2,3-Pentanedione Area Staging Area 4 4 (100%) 3.9 4.5 N/A
2,3-Pentanedione Area Quality Control Laboratory 4 4 (100%) 3.6 7.6 N/A
2,3-Pentanedione Area Roasting 12 12 (100%) 3.7 23.0 N/A
2,3-Pentanedione Area Outside 4 0 (0%) <0.3 <0.3 N/A
2,3-Hexanedione Personal 2nd Floor Offices 5 0 (0%) < 0.2 < 0.5 —
2,3-Hexanedione Personal Front Desk 2 0 (0%) < 0.2 < 0.5 —
2,3-Hexanedione Personal Grinding 4 0 (0%) < 0.2 < 0.5 —
2,3-Hexanedione Personal Packaging — 5LB Bag Line 4 0 (0%) < 0.2 < 0.5 —
2,3-Hexanedione Personal Packaging — Can Line 20 1 (5%) < 0.1 0.4 —
2,3-Hexanedione Personal Packaging — ICA Line 8 0 (0%) < 0.2 < 0.5 —
2,3-Hexanedione Personal Packaging — Pillow Line 6 0 (0%) < 0.1 < 0.6 —
2,3-Hexanedione Personal Production Area 7 1 (14%) < 0.2 0.3 —
2,3-Hexanedione Personal Production Office 9 0 (0%) < 0.2 < 0.5 —
2,3-Hexanedione Personal Quality Control Laboratory 12 0 (0%) < 0.2 < 0.6 —
2,3-Hexanedione Personal Roasting 11 1 (9%) < 0.2 0.4 —
2,3-Hexanedione Area Grinding 8 2 (25%) < 0.2 1.4 —
2,3-Hexanedione Area 2nd Floor Sales Office 4 0 (0%) < 0.2 < 0.5 —
2,3-Hexanedione Area 2nd Floor Library 4 0 (0%) < 0.2 < 0.5 —
Table A1 (cont). OSHA Methods 1013/1016 full-shift personal and area air sampling results by location, 
NIOSH industrial hygiene survey, April 2016
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Analyte Sample Type Location N
Above
LOD
N (%)
Minimum
Concentration
(ppb)
Maximum
Concentration
(ppb)
Above
REL
N
2,3-Hexanedione Area Kitchen 4 0 (0%) < 0.2 < 0.5 —
2,3-Hexanedione Area Blending 4 0 (0%) < 0.2 < 0.5 —
2,3-Hexanedione Area Packaging — 5LB Line 4 0 (0%) < 0.2 < 0.5 —
2,3-Hexanedione Area Packaging — Can Line 4 0 (0%) < 0.2 < 0.5 —
2,3-Hexanedione Area Packaging — ICA Line 4 0 (0%) < 0.2 < 0.5 —
2,3-Hexanedione Area Packaging — Pillow Line 4 0 (0%) < 0.2 < 0.5 —
2,3-Hexanedione Area Off-gas 4 0 (0%) < 0.2 < 0.5 —
2,3-Hexanedione Area Finished Product Racks 4 0 (0%) < 0.2 < 0.5 —
2,3-Hexanedione Area Finished Products Storage 4 0 (0%) < 0.2 < 0.5 —
2,3-Hexanedione Area Front Corner in Production 4 0 (0%) < 0.2 < 0.5 —
2,3-Hexanedione Area Green Bean Storage 4 0 (0%) < 0.2 < 0.5 —
2,3-Hexanedione Area Loading Docks 4 0 (0%) < 0.2 < 0.5 —
2,3-Hexanedione Area Production Office 4 0 (0%) < 0.2 < 0.5 —
2,3-Hexanedione Area Small Personal Grinders 4 0 (0%) < 0.2 < 0.5 —
2,3-Hexanedione Area Staging Area 4 1 (25%) < 0.2 0.8 —
2,3-Hexanedione Area Quality Control Laboratory 4 0 (0%) < 0.2 < 0.5 —
2,3-Hexanedione Area Roasting 12 1 (8%) <0.2 0.8 —
2,3-Hexanedione Area Outside 4 0 (0%) < 0.2 < 0.5 —
Note: NIOSH=National Institute for Occupational Safety and Health; OSHA=Occupational Safety and Health 
Administration; N=number of samples; Above LOD N (%)=number and percentage of samples above limit of detection 
(LOD); < indicates below the limit of detection; Above REL N=number of samples above the NIOSH recommended exposure 
limit (REL); ppb=parts per billion; N/A indicates that NIOSH RELs are specified for personal air samples, and cannot be 
directly applied to area air samples;  “–“ indicates that there is currently no REL for 2,3-hexanedione. 
Table A1 (cont). OSHA Methods 1013/1016 full-shift personal and area air sampling results by location, 
NIOSH industrial hygiene survey, April 2016
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Table A3. Instantaneous* evacuated canister task-based air sampling concentration results, NIOSH 
survey, April 2016
Task Location Task Description Analyte (parts per billion)
Diacetyl 2,3-Pentanedione 2,3-Hexanedione
Blending
Dumping whole French Roast 
coffee beans into hopper along 
blending line
2,146.3 742.6 105.9
Grinding Sealing supersack after beans were ground 1,279.2 407.7 18.7
Removing ground coffee supersack 
from grinder 2,692.3 948.8 37.0
Removing ground coffee supersack 
from grinder 368.7 162.7 7.5
Packaging – Pillow Pack Loading ground coffee into hopper 3,765.2 3,377.3 95.7
Packaging – ICA Rework 12oz. packages 27.6 14.6 1.1
Quality Control Laboratory Cupping – smelling coffee 9.9 7.3 1.5
Cupping – smelling coffee 23.5 14.6 6.0
Cupping – stirring coffee (aroma 
evaluation) 19.4 11.1 2.1
Cupping – tasting coffee 9.4 6.8 < 0.9
Cupping – tasting coffee 21.3 11.8 4.4
Cupping – tasting coffee (start) 18.0 9.4 2.2
Cupping – tasting coffee (end) 14.5 7.4 1.3
Grinding coffee beans for espresso 40.5 19.8 1.8
Grinding coffee beans for espresso 26.5 12.0 1.3
Grinding coffee for cupping 15.8 14.4 < 0.9
Grinding coffee in sample grinder 26.9 16.4 2.7
Grinding coffee in sample grinder 29.4 20.8 2.0
Grinding coffee samples for 
production cupping 74.0 43.6 5.8
Pulling shots of espresso (brewing/
extracting) 24.5 11.0 2.8
Pulling shots of espresso (brewing/
extracting) 25.6 16.9 6.1
Roasting coffee beans in sample 
roaster 25.0 11.2 1.9
Weigh roasted beans 3.7 2.5 1.1
Roasting – Grinders Grinding quality control sample 34.7 16.0 < 0.9
Grinding quality control sample 74.9 53.2 1.9
Grinding quality control sample 97.7 100.8 70.6
Grinding quality control sample 18.2 10.3 1.3
Grinding quality control sample 49.3 34.5 1.7
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Task Location Task Description Analyte (parts per billion)
Diacetyl 2,3-Pentanedione 2,3-Hexanedione
Roasting – Orange Roaster Collect sample of roasted beans 
from destoner 8.0 5.8 < 1.1
Collect sample of roasted beans 
from destoner 6.1 3.0 < 1.1
Pulling out ‘Tryer’ to smell and 
profile roast 14.3 8.1 1.6
Roasting – Red Roaster Pulling out ‘Tryer’ to smell and profile roast 4.2 2.3 < 1.4
Pulling out ‘Tryer’ to smell and 
profile roast 6.5 3.5 < 1.3
Pulling out ‘Tryer’ to smell and 
profile roast 19.1 7.6 < 1.3
Pulling out ‘Tryer’ to smell and 
profile roast 8.0 3.8 < 2.1
Pulling out ‘Tryer’ to smell and 
profile roast 0.9 0.6 0.2
Note: NIOSH=National Institute for Occupational Safety and Health; < indicates below the limit of detection.
*Sampling duration approximately 30 seconds; task-based air samples were collected by placing the inlet of the canister 
sampler in the employee’s personal breathing zone as he/she performed work task to mimic exposure.
Table A3 (cont). Instantaneous* evacuated canister task-based air sampling concentration results, 
NIOSH survey, April 2016
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Table A4. Instantaneous* evacuated canister source air sampling results by location, NIOSH industrial 
hygiene survey, April 2016
Location Source Description Analyte (parts per billion)
Diacetyl 2,3-Pentanedione 2,3-Hexanedione
Blending Blender station 4 at tote discharge; conveyor not running 142.8 76.2 18.8
Grinding Grinding supersack of Breakfast Blend 11,160.1 2,738.7 272.1
Grinding supersack of Breakfast Blend 4,130.8 1,130.9 90.9
Main grinder transfer point into supersack 15.4 7.8 < 0.9
Transfer point of grinder into supersack. 
Origin: El Salvador; Full City roast 1,045.7 543.2 34.6
Transfer point of grinder into supersack. 
Origin: El Salvador; Full City roast 271.2 147.9 9.5
Transfer point of grinder into supersack 4,355.3 2,353.6 85.7
Transfer point of grinder into supersack 70.9 30.2 1.1
Off-Gas Opening of supersack; roasted at 10:00; ground at 11:00 10,541.0 4,122.8 204.6
Packaging 5LB bag line — outside enclosure where bag is filled 27.8 10.4 1.3
5LB bag line — where 2 bags are packed into 
cardboard box 29.6 10.7 0.9
5LB bag line —  at front of auto-sealer 
outside of glass door 16.3 5.6 1.2
Can line — transfer point of transport hopper 
to feed hopper 19.3 9.3 < 0.9
Can line — point where beans enter can; 
French Roast blend 2,086.5 823.2 82.5
Can line — at top of hopper where supersack 
is emptied 55.1 21.1 2.8
Can line — transfer point of beans into can 
line via All-Fill hopper 124.6 66.0 4.2
Can line — transfer point of beans into can 
line via All-Fill hopper 113.7 60.0 4.3
Hand packing at All-Fill station; ground dark 
roast blend 170.3 50.7 4.1
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Location Source Description Analyte (parts per billion)
Diacetyl 2,3-Pentanedione 2,3-Hexanedione
ICA line — supersack of freshly ground 
coffee from Mexico; medium & Vienna roast 26,406.1 13,138.5 377.6
ICA line — inside open door below hopper 
during repair 20.1 7.6 1.3
Production 
Area
Small personal grinders — grinding Uganda 
Med Blend 112.6 104.0 3.4
Small personal grinders — grinding Uganda 
Med Blend 11.5 5.0 < 0.9
Quality Control 
Laboratory Cupping — at cup at beginning of tasting 15.9 7.7 2.7
Cupping — at cup at end of tasting 19.4 9.6 < 0.9
Cupping — stirring coffee 30.2 19.8 1.8
Espresso — pulling espresso shots 467.3 430.4 17.1
Espresso grinder 809.3 679.3 27.4
Grinding — at sample grinder 142.1 73.8 9.3
Grinding — at sample grinder 249.7 208.0 9.4
Roasting Orange roaster destoner — Breakfast Blend 12.0 3.9 < 0.9
Orange roaster destoner — Breakfast Blend 63.5 18.0 1.2
Orange roaster destoner — Breakfast Blend 57.4 17.3 2.1
Orange roaster door to cooling tray — 
Breakfast Blend 11.8 3.9 < 0.9
Orange roaster door to cooling tray — 
Breakfast Blend 16.7 8.0 < 0.9
Orange roaster transfer point of cooling tray 
to destoner 4.5 2.3 < 0.9
Orange roaster transfer point of cooling tray 
to destoner 5.5 2.4 < 1.0
Orange roaster transfer point of cooling tray 
to destoner 12.6 11.7 11.5
Table A4 (cont). Instantaneous* evacuated canister source air sampling results by location, NIOSH 
industrial hygiene survey, April 2016
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Location Source Description Analyte (parts per billion)
Diacetyl 2,3-Pentanedione 2,3-Hexanedione
Roasting Orange roaster cooling bin discharge to destoner 27.7 13.8 2.2
Red roaster door into cooling tray 10.9 3.2 < 1.2
Red roaster door into cooling tray — Vienna 
Med Roast 37.8 56.5 76.1
Red roaster cooling bin discharge to destoner 
— opening closed 30.4 12.7 1.4
Grinding sample of Breakfast Blend — top of 
bag at grinder discharge 2.2 0.9 < 0.6
Grinding sample of Breakfast Blend — top of 
bag at grinder discharge 67.6 51.2 1.7
Note: NIOSH=National Institute for Occupational Safety and Health; < indicates below the limit of detection for the 
instrument used to detect the analyte (i.e., diacetyl, 2,3-pentanedione, or 2,3-hexanedione%). *Sampling duration 
approximately 30 seconds; source-based air samples were collected by placing the inlet of the canister sampler close to 
a source.
Table A5. Instantaneous* evacuated canister pre-and post-shift background air sampling results, 
NIOSH industrial hygiene survey, April 2016
Tuesday 04/20/2016 Thursday 04/22/2016
Concentration (parts per billion)
Location Analyte AM PM AM PM 
Middle of Production Area Diacetyl 11.8 25.5 5.9 20.3
2,3-Pentanedione 4.2 8.4 2.0 7.3
2,3-Hexanedione 1.2 1.4 < 1.2 1.1
Between Staging Area  & Diacetyl 9.9 38.2 5.6 19.3
Green Bean Storage 2,3-Pentanedione 3.5 20.1 2.6 8.6
2,3-Hexanedione 1.2 1.3 1.1 1.7
Note: NIOSH=National Institute for Occupational Safety and Health; < indicates result was below the limit of 
detection.
*Sampling duration approximately 30 seconds.
Table A4 (cont). Instantaneous* evacuated canister source air sampling results by location, NIOSH 
industrial hygiene survey, April 2016
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Table A6. Bulk coffee sample results using headspace analysis, NIOSH industrial 
hygiene survey, April 2016
Bulk Sample Description Analyte (parts per billion)
Bean Type Origin Roast Diacetyl 2,3-Pentanedione 2,3-Hexanedione
Whole Peru Decaf Vienna 2124.7 1638.1 <
Ground Peru Decaf Vienna 402.4 389.3 <
Whole Honduran Dark Medium 1171.3 1462.8 <
Ground Honduran Dark Medium 871.4 1004.4 <
Whole Mexican Medium 865.6 927 271.7
Ground Mexican Medium 450.1 805 <
Whole Peru Decaf Full City 1806.4 2005.1 <
Ground Peru Decaf Full City 934.1 1096.9 <
Whole Honduran/Peru French 974.7 421.5 <
Ground Honduran/Peru French 314.0 105.8 300.8
Ground Mexican Medium & Vienna 704.4 681.5 222.8
Note: NIOSH=National Institute for Occupational Safety and Health; < indicates result was below the 
limit of detection.
Table A7. Real-time air monitoring for carbon dioxide, carbon monoxide, total volatile 
organic compound, temperature, relative humidity, NIOSH industrial hygiene survey, 
April 2016
Location CO2 ppm CO ppm TVOC ppm Temp °F RH %
Off-gas Area 610 1.4 735 67.6 37.8
Main Grinder: to right of 
discharge 596 7.7 — 69 34.7
Main Grinder: to left of discharge 749 25.7 3,270 69.3 22.4
Main Grinder: behind grinder 770 6.6 953 71.7 30.0 
Red Roaster 666 3.9 985 72.3 20.6
Roaster Sample Grinders 794 5.8 1,171 72.2 29.1
Can Line 553 7.8 1,251 73.3 36.9
ICA Line 576 6.2 1,207 72.5 38.2
Note: NIOSH=National Institute for Occupational Safety and Health; CO2=carbon dioxide; 
CO=carbon monoxide; TVOC=total volatile organic compound; ppm=parts per million; °F=degrees 
Fahrenheit; RH %=percent relative humidity; —=not measured
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The Health Hazard Evaluation Program investigates possible health hazards in the workplace 
under the authority of the Occupational Safety and Health Act of 1970 (29 U.S.C. § 669(a)
(6)). The Health Hazard Evaluation Program also provides, upon request, technical assistance 
to federal, state, and local agencies to investigate occupational health hazards and to prevent 
occupational disease or injury. Regulations guiding the Program can be found in Title 42, Code 
of Federal Regulations, Part 85; Requests for Health Hazard Evaluations (42 CPR Part 85).
Disclaimer 
The recommendations in this report are made on the basis of the findings at the workplace 
evaluated and may not be applicable to other workplaces.
Mention of any company or product in this report does not constitute endorsement by the 
National Institute for Occupational Safety and Health (NIOSH).
Citations to Web sites external to NIOSH do not constitute NIOSH endorsement of the 
sponsoring organizations or their programs or products. NIOSH is not responsible for the 
content of these Web sites. All Web addresses referenced in this document were accessible as 
of the publication date.
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